Pomerantz LLP Achieves Significant Victory for Damaged Deutsche Bank AG Investors

POMERANTZ MONITOR | SEPTEMBER OCTOBER 2022

By The Editors

In a significant victory for damaged Deutsche Bank AG investors, the Bank has agreed to pay nearly $26.3 million to end a proposed class action against it on behalf of investors who acquired Deutsche Bank stock between March 14, 2017, and May 12, 2020. Pomerantz is sole lead counsel representing the putative class of plaintiffs in the litigation. The recovery represents approximately 49.4% of the likely recoverable damages in this case, which is well above the median recovery of 1.8% of estimated damages for all securities class actions settled in 2021. Plaintiffs have moved the court for approval of the settlement.

The complaint, filed in 2020, alleges that Deutsche Bank made materially false and misleading statements about its anti-money-laundering (“AML”) deficiencies and did not properly monitor customers it considered high risk, such as financier and accused sex offender Jeffrey Epstein. For example, defendants repeatedly assured investors that Deutsche Bank had “developed effective procedures for assessing clients (Know Your Customer or KYC) and a process for accepting new clients in order to facilitate comprehensive compliance,” and insisted that “[o]ur KYC procedures start with intensive checks before accepting a client and continue in the form of regular reviews.” Defendants also claimed Deutsche Bank’s “robust and strict” KYC program “includes strict identification requirements, name screening procedures and the ongoing monitoring and regular review of all existing business relationships,” with “[s]pecial safeguards . . . implemented for... politically exposed persons [“PEPs”] ...”

In truth, however, far from implementing a “robust and strict” KYC program with “special safeguards” for PEPs, defendants repeatedly exempted high-net-worth individuals and PEPs from any meaningful due diligence, enabling their criminal activities through the use of the Bank’s facilities. For example, Deutsche Bank continued “business as usual” with Jeffrey Epstein even after learning that 40 underage girls had come forward with testimony that he had sexually assaulted them. Deutsche Bank’s former CEOs also on[1]boarded, retained, and serviced Russian oligarchs and other clients reportedly engaged in criminal activities, including terrorism.

In making its case, Pomerantz received statements from eleven confidential witnesses, including multiple internal auditors.

In 2020, the media began to cover Deutsche Bank’s internal problems, including news of a harshly critical Federal Reserve report on the bank’s AML and control issues, a $150 million fine from New York State’s financial regulator for AML misdeeds, and its Epstein relationship. According to a Bloomberg news article on July 16, 2020, Deutsche Bank, in a July 7 message to staff, stated that adding Epstein as a client in 2013 “was a critical mistake and should never have happened.” In response to these disclosures, Deutsche Bank’s stock price dropped, wiping out millions of dollars in market capitalization.

According to Partner Emma Gilmore, who leads the litigation, “We are very pleased with the result achieved in this matter. The extraordinary 50% recovery the Firm achieved on behalf of Deutsche Bank’s investors should be a wakeup call for all corporations who choose to conduct business with unsavory characters. As a woman prosecuting the case against Deutsche Bank, this victory is all the more rewarding.”

Additional Pomerantz attorneys litigating this case are Jeremy A. Lieberman, Dolgora Dorzhieva, and Villi Shteyn. The case is Karimi et al. v. Deutsche Bank AG et al., No. 1:22-cv-02854, in the U.S. District Court for the Southern District of New York.

SEC Proposes Amendment to Rule Governing Shareholder Proposals

POMERANTZ MONITOR | SEPTEMBER OCTOBER 2022

By Jonathan D. Park

On July 13, 2022, the U.S. Securities and Exchange Commission (the “SEC”) proposed amendments to the rule governing the process for including shareholder proposals in a company’s proxy statement (the “Proposed Rule”). If adopted, the Proposed Rule will limit the ability of companies to exclude shareholder proposals from proxy statements.

Shareholders’ ability to make proposals to be included in a company’s proxy materials and voted on by all shareholders is an important means of engagement between shareholders and public companies. Rule 14a-8, promulgated by the SEC pursuant to the Securities Exchange Act of 1934, requires reporting companies subject to federal proxy rules to include shareholder proposals in their proxy statements, subject to certain requirements. The rule permits companies to exclude shareholder proposals from proxy statements on thirteen substantive grounds. The Proposed Rule would amend three of those grounds: (1) the substantial implementation exclusion, (2) the duplication exclusion, and (3) the resubmission exclusion.

The Proposed Rule aims to provide clarity to all stakeholders concerning when shareholder proposals may be excluded from proxy statements. Further, it will narrow the grounds on which shareholder proposals may be excluded, thus permitting greater shareholder engagement with management.

Of the three provisions addressed by the Proposed Rule, the substantial implementation exclusion is the most frequently invoked by company “no-action requests” concerning shareholder proposals. Disagreements between a company and a shareholder as to whether a proposal must be included in a proxy statement is often resolved by the SEC staff in response to company requests for the Commission to issue a “no-action letter” stating that it would take no action against the company if it excluded the shareholder proposal. Of the no-action requests received by the SEC during the 2019, 2020, and 2021 proxy seasons, 39% invoked the substantial implementation exclusion. By contrast, the duplication exclusion and the resubmission exclusion were invoked in 5% and 1%, respectively, of no-action requests.

The Substantial Implementation Exclusion

Rule 14a-8(i)(10) currently permits companies to exclude shareholder proposals that “the company has already substantially implemented.” The Proposed Rule would permit companies to exclude a shareholder proposal if “the company has already implemented the essential elements of the proposal” (emphasis added).

The SEC staff’s interpretation of the existing rule—that is, whether a proposal has already been “substantially implemented”—calls for consideration of whether the company’s “policies, practices and procedures compare favorably with the guidelines of the proposal” as well as whether the company has addressed the proposal’s underlying concerns and essential objectives.

Shareholders report that this has led to debates regarding the “essential purpose” of a proposal, and that companies have excluded proposals that addressed similar subject matter as existing company procedures even where the proposal set forth a materially different action. For instance, Exxon Mobil sought to exclude a shareholder proposal calling for the company to state whether and how it planned to reduce its carbon footprint in alignment with the Paris Climate Accords. Exxon argued that the proposal was excludable because, among other things, it had already reported information concerning its approach to climate change. It did not, however, report if it intended to align its business with the Paris Climate Accords or state how it intended to accomplish that goal. Nevertheless, the SEC staff agreed with Exxon, finding that Exxon’s disclosures “compared favorably” with the shareholder proposal and, therefore, that Exxon had already “substantially implemented” the proposal.

Under the Proposed Rule, it appears that this proposal would not be excludable under the substantial implementation exclusion because its “essential element”— that the company state if and how it intends to align its business with the Paris Climate Accords—is distinct from a company’s reporting about its general approach to climate change. The SEC stated that the Proposed Rule is expected to promote certainty because a proposal’s “essential elements” are likely easier to define, and less subject to debate, than its “essential purpose.” Therefore, all stakeholders would have greater certainty as to whether a proposal may be excluded under the substantial implementation exclusion.

Shareholder proponents are likely to have greater success avoiding exclusion on this basis if they develop proposals that include specific and identifiable essential elements that are distinct from the company’s current practices. This is illustrated by SEC commentary discussing the Proposed Rule. The SEC addressed, as an example, the fact that historically its staff had permitted companies to exclude proposals to adopt a bylaw permitting an unlimited number of shareholders who collectively have owned 3% of the company’s outstanding common stock for 3 years to nominate up to 25% of the company’s directors, where the company’s bylaws permitted a group of up to 20 shareholders to aggregate their holdings to meet such a threshold. The SEC explained: “Under the proposed amendment, because the ability of an unlimited number of shareholders to aggregate their shareholdings to form a nominating group generally would be an essential element of the proposal, exclusion would not be appropriate.”

The Duplication Exclusion

Rule 14a-8(i)(11) currently permits companies to exclude a shareholder proposal that “substantially duplicates another proposal previously submitted by another proponent that will be included in the company’s proxy materials for the same meeting.”

The Proposed Rule would provide that a proposal “substantially duplicates” another proposal if it “addresses substantially the same subject matter and seeks the same objective by the same means.”

Under the existing standard, the SEC has focused on whether proposals share a “principal thrust” or focus. The SEC stated that this framework can be difficult to apply in a consistent and predictable manner because there are often several ways to determine a proposal’s principal thrust. By contrast, the Proposed Rule sets forth a more precise standard for the duplication exclusion that the SEC expects it can more easily apply consistently.

The proposed amendment to the duplication exclusion is also narrower than the existing standard, so proposals are less likely to be excludable on this basis. As a result, it is more likely that shareholders will face the option of voting on multiple proposals concerning the same or similar topic at the same shareholder meeting. The SEC noted that this may cause shareholder confusion and could lead to difficulties if multiple proposals, perhaps with overlapping or even conflicting objectives, are approved at the same meeting. Nevertheless, the SEC stated that shareholder consideration of similar proposals may increase the likelihood that proposals that align closely with shareholder objectives will be implemented.

Because the duplication exclusion operates in favor of the earlier-submitted proposal, narrowing the exclusion will reduce the incentive for a shareholder to rush to submit a proposal quickly to avoid exclusion on this basis. It will also lessen the likelihood that a shareholder will be able to block proposals from other shareholders concerning the same topic.

The Resubmission Exclusion

Rule 14a-8(i)(12) currently permits companies to exclude a shareholder proposal that “addresses substantially the same subject matter as a proposal, or proposals, previously included in the company’s proxy materials within the preceding five calendar years” and that was voted on at least once in the last three years and did not receive shareholder support above a certain threshold.

Observers may recall that in 2020, the SEC increased the thresholds applicable to the resubmission exclusion. Specifically, the Commission adopted a new rule providing that the resubmission exclusion applied where a proposal was included in the company’s proxy materials within the preceding five years, was voted on within the preceding three years, and the most recent vote was: (1) less than 5% of votes cast, if the proposal was previously voted on once (up from 3%); (2) less than 15% of votes cast, if the proposal was previously voted on twice (up from 6%); and (3) less than 25% of votes cast, if the proposal was previously voted on three times or more (up from 10%).

As a result of increasing these thresholds, more shareholder proposals became vulnerable to exclusion on this basis. Some shareholders noted that this could prevent or delay shareholder consideration of proposals on emerging issues that may have received little support when first introduced. Moreover, because the current resubmission exclusion applies broadly to proposals with “substantially the same subject matter,” it can prevent shareholders from refining their proposals and seeking a vote in a subsequent year.

Under the Proposed Rule, the resubmission exclusion would apply where a proposal “addresses the same subject matter and seeks the same objective by the same means” as an earlier proposal. This is narrower than the existing rule. First, the exclusion would apply only where a proposal addresses the “same” subject matter, not just “substantially the same” subject matter. Second, it would apply only if a proposal “seeks the same objective” as an earlier proposal. Thus, a shareholder proposal concerning a given subject would not block a later proposal on the same topic if the two proposals sought different objectives. Third, the exclusion would apply only if the proposal uses the “same means” as an earlier proposal.

Therefore, if the resubmission exclusion is amended as proposed, shareholder proposals are less likely to be excludable on this basis.

Conclusion

 The Proposed Rule is likely to increase shareholders’ ability to have their proposals included in proxy materials and voted upon by other shareholders. Major institutional investors have already expressed support for the Proposed Rule in comments submitted to the SEC.

The deadline for public comments expired on September 12, 2022. The SEC is expected to announce a final rule in the near future. Alternatively— though less likely—the SEC may take no further action (allowing the current rules to remain in place) or may issue a revised proposed rule for further comment.

Q&A: Dr. Daniel Summerfield

POMERANTZ MONITOR | SEPTEMBER OCTOBER 2022

Partner Jennifer Pafiti recently interviewed Dr. Daniel Summerfield, Pomerantz’s new Business Development Director for the United Kingdom and Co-Manager of the Firm’s London office.

Jennifer Pafiti: Please describe the path that led you to your new role with Pomerantz.

Daniel Summerfield: I have worked with institutional investors in a variety of roles and in various markets over the years and believe that pension funds can and should be a force for good. For that to happen, trustees of pension funds should utilize the means available to them to effect the changes that will ensure the long-term performance of their funds and the companies in which they invest. Those means include litigation. Joining Pomerantz, a firm that not only fights to protect investors, but also serves as an advocate for good corporate governance, seemed like the next logical step in my career.

JP: What are the most significant differences between securities litigation in the U.S. and U.K.?

DS: Securities litigation in the U.K. remains quite challenging when compared to the U.S., Germany, the Netherlands and Australia. The U.K. is catching up, but slowly. In the last decade, the English courts have taken steps to address class actions in a much more favorable way and we’ve seen some civil society groups utilize class actions in cases against companies such as Shell.

JP: What is the appetite of U.K. institutional investors for pursuing securities litigation?

DS: There has been a seismic shift in that regard, at least in the context of the relatively slow changes that take place in the U.K. market compared to the U.S. Fiduciaries are beginning to sit up and take note of the critical role of lead plaintiff. I would argue that, until recently, institutional investors in the U.K. viewed class action securities litigation as merely a way of seeking financial compensation. With the continued amplification of ESG concerns, active engagement in litigation is also being viewed as a way to bring about corporate governance reforms which otherwise would not have been achieved. When USS, even as a relatively conservative pension scheme, stepped forward to serve as lead plaintiff in the Petrobras case, it demonstrated to others that it is not such an onerous responsibility when you have the right law firm as a partner.

JP: You mentioned ESG issues, an area in which you have deep experience. Can you give an example? DS: I have been engaged with regulators, policy makers and pension funds around the globe to bring about governance changes, for example, in getting the concept of Responsible Investment into the mainstream thinking and practices of pension funds as well as introducing market reforms in areas such as hedge fund governance. And I have been involved beyond the traditional staple of engagement tactics. In 2005, USS, collectively with U.S., Australian and European funds, successfully sued Rupert Murdoch’s News Corp in Delaware Chancery Court. The suit alleged that News Corp defrauded investors by refusing them the right to vote on an extension of a poison pill provision, as it had promised it would do. The company had claimed that it did not need to honor its promise to shareholders because the board had the right to change the poison pill policy. This was a significant win for shareholder rights and for corporate governance reform, and it has been frequently cited since.

JP: What is the most important lesson you learned from leading USS through their role as lead plaintiff in its historic $3 billion Petrobras litigation?

DS: I would cite three important lessons learned. First, the paramount importance of good recordkeeping. We could not have achieved what we did had we not had those records in place. Second, the importance of choosing a law firm with the experience, expertise, and patience to help you navigate the challenging path that a complex case like Petrobras presents. And third, I would say, is the importance of resilience. We took the role of lead plaintiff seriously and did not waiver in our responsibility to represent our members and the class. And neither did Pomerantz. All the parties remained resolute in terms of what we wanted to see as an outcome. We achieved it together.

JP: Why should it matter to institutional investors in the U.K. that Pomerantz is now local in London?

DS: While Pomerantz began as a U.S. law firm, it has grown to be a leading global firm in a globalized marketplace. As Jeremy Lieberman has said, ‘where can you say a trade takes place today when it is placed online on one side of the world, transmitted over satellites, and executed on an exchange on a different continent?’ Pomerantz pursues securities litigation wherever in the world the need arises, and the jurisdiction supports. What we can now do as a law firm operating in London is to ensure that U.K. investors and pension funds have a full breadth of understanding of what is going on in the U.S. and the world, and work closely with them, guiding them through the decision-making process regarding specific cases in which they have exposure.

JP: How do you see securities litigation evolving in the U.K.?

DS: It’s about making it more mainstream. Securities litigation is still relatively obscure in the UK, misunderstood by many and taken up by a few. I think where we need to get to, and what I think the next stage in this process is, is to ensure that securities litigation is seen as part of part of the stable of tools that are available to investors rather than as an exception to the rule.

JP: If there was one thing you want institutional investors to know about securities fraud, what would it be?

DS: The sky is not going to fall in just because you are involved in this process. Pursuing securities litigation does not mean that you will automatically lose influence or contact with a company. In a sense, it is par for the course, particularly in the U.S. Securities litigation is also not just about backward-looking financial redress. As I mentioned before, it is also about future-proofing the companies in which we invest and sometimes acting as a deterrent to that company and others who might be tempted to follow in their steps. The changes that we can bring about through class actions can have a very positive, long-lasting outcome.

California’s Statutory Efforts to Achieve Board Diversity

POMERANTZ MONITOR | JULY AUGUST 2022

By Lauren Molinaro

Women—Black and Latina women in particular—remain vastly underrepresented in corporate boardrooms. While studies repeatedly show that an increase in board diversity leads to better business outcomes, progress has been frustratingly slow: As of 2020, women account for around 20% of corporate board rooms, and only 5% of CEOs are women. People of color represent only around 15% of directors on Fortune 500 boards. A lack of diversity at the board level affects corporate governance, as the board establishes a corporation’s vision and mission. Research has shown that diversity of thought and perspective leads to better investment returns, better business strategies, and stronger organizations overall. Companies with diverse boards may have profits 43% higher than those that do not, and compared to individual decision makers, diverse teams make better decisions 87% of the time. In recent years, state lawmakers have increasingly focused on improving workplace diversity through legislation that encourages or requires diversity on corporate boards.

A number of state laws require corporations to disclose the total number of directors on their board and total number of female directors and/or individuals from “underrepresented communities” in their Annual Reports. These “show or tell” laws are built to withstand legal challenges by requiring transparency rather than mandating specific quotas. Only two states—Washington and California— have enacted laws mandating the number of women and individuals from “underrepresented communities” on the boards of directors of publicly traded corporations based in their respective states. The futures of such mandate laws remain up in the air following a pair of recent legal defeats in California state courts.

In 2018, California lawmakers enacted SB 826, requiring publicly held companies with executive offices in California to include minimum numbers of women on their boards of directors by the close of 2019, no matter where they are incorporated. The California Secretary of State has the authority to impose fines up to $300,000 per violation for noncompliance.

In 2020, lawmakers approved a similar bill, AB 979, requiring covered California corporations to have a minimum of one director from an underrepresented community by the close of 2021. The bill defines a director from an “underrepresented community” as “an individual who self-identifies as Black, African American, Hispanic, Latino, Asian, Pacific Islander, Native American, Native Hawaiian or Alaska Native; or who selfidentifies as gay, lesbian, bisexual or transgender.” Additional requirements apply by the close of 2022, depending on the size of the board.

In April and May, two California state judges struck down the laws in separate decisions, finding SB 826 and AB 979 to violate the Equal Protection Clause of the California Constitution.

To withstand constitutional scrutiny, a statute employing racial and other classifications must be narrowly tailored to address a specifically identified harm that the state has a compelling interest in remediating. In California, if the state wants to create classifications based on sex, it must also have a compelling interest and its action must be necessary to achieve that purpose. In striking down the laws, both courts found SB 826 and AB 979 unconstitutional on their faces. Both laws unconstitutionally treated similarly situated individuals–qualified potential corporate board members–differently based on their racial, sexual orientation, and gender identity groups, requiring that a specific number of board seats be reserved for members of a group, thereby excluding members of other groups from those seats.

The courts found the state failed to show a compelling government interest by failing to produce evidence of specific past discrimination in board selection. In doing so, the courts stressed that while rectifying specific and intentional discrimination can be a compelling government interest, remedying generalized, non-specific allegations of discrimination is not. For example, the state cited only statistics about the number of women on corporate boards as compared to men but failed to identify specific instances of women being discriminated against by a specific corporation in the corporation’s board process. The courts also concluded that the state failed to show the statute was narrowly tailored to address the perceived discrimination in light of available gender-neutral alternatives, such as amending existing anti-discrimination laws or enacting a new anti-discrimination law focusing on the board selection process. The courts did not criticize the goal of the California legislature in enacting the statute, but the specific means it had taken to serve the state’s commitment to equal treatment and opportunity.

It now appears that California’s statutory efforts to achieve board diversity through mandated seats for women and individuals from underrepresented communities is on hold. Despite the setback, public pressure on companies to advance board diversity remains strong. At least a dozen other states have drafted or passed board diversity legislation. As mentioned above, the vast majority of these laws differ drastically from California’s in that they do not mandate a specific number of individuals on any corporate board, but merely require disclosure, which the California state courts’ rulings seemingly deem permissible. While a similar law in Washington requires a specific percentage of female board members, no penalties are given for compliance failures. The California rulings also have no effect on a rule adopted by Nasdaq and approved by the Securities and Exchange Commission (SEC) requiring most companies listed on the Nasdaq to have at least two self-identified “diverse” board members or explain in writing why they do not. Nasdaq has emphasized that the rule establishes a disclosure-based framework, and not a mandate or quota. Nasdaq’s Listing Rules currently face a challenge in the Fifth Circuit, where the Court will review the SEC’s approval of these rules and determine whether they violate the Equal Protection Clause of the U.S. Constitution.

However, legislation is only one of the driving forces behind diversifying corporate boardrooms. As shareholders elect the board, institutional shareholders have shown a willingness to utilize their leverage to apply pressure to influence companies to improve diversity at the board level. A lack of diversity at the board level is considered a risk for institutional investors. Stakeholders may act against companies lacking board diversity by voting against or withholding votes from existing directors or otherwise exerting public pressure. Institutional investors have made bold public statements on their commitments to pressure companies to increase board diversity and be more transparent on their current diversity practices. Large investors like Blackrock, State Street, and Vanguard have publicly expressed a desire to see corporate boards diversify their ranks and have advocated for board diversity through their proxy voting policies.

Concurrently, shareholder groups, employees, and consumers have also been challenging the lack of diversity on corporate boards. Amid escalating battles over diversity, activist shareholders are demanding change. Shareholder derivative lawsuits have recently begun targeting major public and private companies. Alleging that boards have breached their fiduciary duties in creating an “old boys’ club” corporate culture, these activist shareholder lawsuits unequivocally focus on the board’s apparent disinterest in promoting diversity. Through litigation and subsequent settlements, companies have been forced to overhaul their policies, procedures, and oversight functions as well as change the composition of their boards.

Even if legislation to diversify boardrooms remains in question, investors may wield their power and influence to continue to pressure companies to make progress. Investors may emphasize that companies that fail to address this important issue do so at their own peril. In response, companies may choose to adopt corporate governance codes or strategic plans to diversify, such as engaging in outreach to non-traditional avenues of board recruitment, for example. While efforts to diversify boards are long overdue, the gains being made, however slow, are bound to have a positive impact on company culture, corporate performance, and shareholder value.

Delaware to Expand Liability Protections to Senior Officers

POMERANTZ MONITOR | JULY AUGUST 2022

By Gustavo F. Bruckner and Carolyn Fontana

On June 14, 2022, the Delaware Legislature passed legislation that would allow Delaware corporations to adopt exculpation clauses limiting or eliminating the monetary liability of certain officers of corporations. If approved by Delaware Governor John Carney, the proposed changes to the Delaware General Corporation Law (DGCL) would expand liability protections to officers that are similar to those currently granted to directors. This proposed expansion has caused concern in some corners that the amendment will encourage bad behavior by company officers who will now have a shield protecting them.

Under Delaware law, directors and officers owe certain fiduciary duties to their corporations and stockholders, including duties of care and loyalty. Section 102(b)(7) of the DGCL authorizes Delaware corporations to include in their certificates of incorporation “[a] provision eliminating or limiting the personal liability of a director to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director,” otherwise known as an exculpatory clause. Under current law, such exculpatory clauses cannot eliminate or limit the liability of a director for any breach of the duty of loyalty, for any acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, for unlawful payment of dividends or unlawful stock repurchases, or where a director receives an improper personal benefit.

These liability protections for breaches of the duty of loyalty and the duty of care given to directors are not currently afforded to officers. Rather, officers currently face potential personal liability for both duty of care and duty of loyalty claims. Duty of care claims can include, for example, alleged disclosure violations. Duty of loyalty claims, meanwhile, often occur when a director profits at the expense of the corporation.

If the proposed changes were enacted, the liability shield for senior officers would expand, thus eliminating or limiting their personal liability in stockholder actions seeking damages for alleged duty of care breaches, but not breaches of the duty of loyalty. The senior officers covered by the new changes are chief executive officers, presidents, chief financial, operating, and legal officers, controllers, treasurers, and chief accounting officers, as well as any other persons identified as “named executive officers” in the corporation’s most recent SEC filings. These senior officers would remain at risk for derivative suits for loyalty breaches pursued in the company’s name and for the company’s benefit.

These proposed changes arose due to criticism over the difference in liability faced by directors and officers. That is, stockholder plaintiffs have increasingly asserted breach of fiduciary duty claims against officers rather than directors, despite officers and directors owing the same fiduciary duties of loyalty. As a result of these claims, Delaware courts have denied motions to dismiss brought by officers, while granting those same motions with respect to the company’s directors.

Proponents of the amendment include firms representing corporations whose officers may now be protected with this liability shield. These firms further argue that these officer duty of care claims are merely new litigation tactics by shareholder plaintiffs’ lawyers to garner potentially lucrative fee awards in cases where these proponents believe any damages case should be dismissed.

Plaintiffs firms have voiced strong opposition to these proposed changes, arguing that they are at best unwarranted. In addition to their lack of necessity, they argue that the changes also needlessly exculpate a range of careless or reckless behavior for which an officer should face potential liability. Without the risk of facing potential liability, senior officers lack a personal motive to act with due care, undermining their crucial role as gatekeepers for the company by preventing corporate misconduct from occurring under their watch.

The changes have also been criticized as creating a solution for a problem that does not exist. More specifically, opponents argue that the drafters conflate the necessary protections for directors with those for officers, as directors face problems with potential liability that officers of the corporation do not face. This can be seen when looking at the origins of director protections, which were expanded in the 1980s following the Delaware Supreme Court’s 1986 decision in Smith v. Van Gorkom. Van Gorkom identified two problems created by holding directors personally liable for negligence: (1) decreasing the pool of qualified people willing to serve as directors of Delaware corporations out of fear of personal liability for corporate actions, and (2) drastically increasing the cost of director and officer liability insurance. To prevent these problems, Delaware enacted strong director liability protections.

Delaware, as the state of incorporation of most corporations in the United States, maintains some of the strongest liability protections in the country, although states like New York have strong director liability protections.

Later, in 2009, the Delaware Supreme Court clarified the duties of officers in Gantler v. Stephens, explaining that officers owe the same fiduciary duties as directors, but do not have comparable exculpatory clauses to protect them from personal liability. This distinction comes from the fact that officers do not face the same problems as certain directors when it comes to personal liability. That is, the changes put in place after Van Gorkom were created to allow independent directors who are not employees of the company to serve on the board of that company without any concern of potential liability for breaches of their duty of care. Officers, on the other hand, don’t have this problem because they lack independence and are actively involved in the day-to-day operations of the corporation.

In addition to the issues regarding differences between officers and directors, opponents of the proposed expansion of liability protections raise the question of why officers can be liable in some situations but not others. For example, a CEO of a corporation making millions of dollars a year could, conceivably, be potentially liable to a customer if they acted negligently and injured that customer. At the same time, if these proposed changes go through, that same CEO would not be liable for acting grossly negligently with respect to stockholders in connection with a sale of company assets.

Moreover, opponents argue, claims of gross negligence are already rare, with only a few cases in recent years permitting a duty of care claim to move forward against a corporate officer, and those cases involved unique situations in which the plaintiffs had the burden to prove their claims. So, the argument that officer duty of care claims are merely litigation tactics for getting higher fee awards is unfounded, they contend, as the claims are few and those which have survived a motion to dismiss have been properly pleaded by stockholder plaintiffs trying to remedy bad business behavior.

These proposed changes, if approved by Governor Carney during the current legislative session, will present significant challenges for shareholder plaintiffs trying to sue officers for allegedly careless behavior. Meanwhile, the changes could also save companies from having to defend claims that they believe have no merit and thus should not warrant damages. Now that the legislation has passed both the Delaware Senate and General Assembly, there is pressure on the Governor to sign it this year, before the legislative session ends. Bills left on the table unsigned when a session concludes must start the process anew.

Pomerantz Achieves $20 Million Settlement Over Allegedly Bad iPhone Update

POMERANTZ MONITOR | JULY AUGUST 2022

By The Editors

On May 3, 2022, after six years of hard-fought litigation, Pomerantz and co-counsel achieved a significant victory on behalf of consumers by securing a $20 million settlement, pending final approval of the court, in a consumer class action against Apple, Inc., on behalf of iPhone owners. The motion to settle, filed in U.S. District Court for the Eastern District of New York and unopposed by Apple, would entitle the class members to a recovery of between $15 to $150 per device owned, depending on how many class members file claims. The named plaintiffs consider this a successful result, as the secondary market price of the phones, according to Apple, is not more than that.

In October 2020, Pomerantz successfully fought to have the court certify two classes of iPhone users: All individuals and entities in New York (Class One) or New Jersey (Class Two) who currently own or have owned an iPhone 4S that was updated to any version of iOS 9 from any version of iOS 7 or iOS 8.

Then, in February 2021, Plaintiffs defeated Apple’s Rule 23(f) Petition seeking permission from the U.S. Court of Appeals for the Second Circuit to appeal the district court’s class certification decision.

Plaintiffs alleged that Apple misrepresented iOS 9 by telling consumers that the software update would enhance the performance of their devices, when this was not in fact the case. After the update, Plaintiffs’ devices slowed down significantly. According to Plaintiffs’ Amended Complaint:

The update significantly slowed down their iPhones and interfered with the normal usage of the device, leaving Plaintiffs with a difficult choice: use a slow and buggy device that disrupts everyday life or spend hundreds of dollars to buy a new phone. Apple explicitly represented to the public that iOS 9 is compatible with and supports the iPhone 4s. This is also obvious from the fact that Apple made the software available for the iPhone 4s, but not for older versions of the iPhone.

Discovery spanned four years and included over 15 depositions, the review of over 48,000 documents – totaling over 539,000 pages – and the submission of expert reports totaling over 770 pages.

“This case involved the application of sophisticated legal issues to a highly complex technological consumer product,” said Pomerantz Partner Michael Grunfeld, who led the litigation. “We are pleased that we were able to achieve this favorable result for the Class by prevailing at every stage of the litigation before reaching this settlement near the close of discovery in the merits phase of the litigation.”

Pomerantz's 2022 Corporate Governance Roundtable

POMERANTZ MONITOR | JULY AUGUST 2022

By Kaylan Perez

Pomerantz delivered an outstanding roundtable with experts presenting on a variety of corporate governance topics. I really appreciated the opportunity to meet fiduciaries and compare viewpoints.”

Megan Peitzmeier, Senior Staff Attorney, Colorado PERA

On June 14, Pomerantz hosted its 2022 Corporate Governance Roundtable in the Waldorf Astoria Hotel in Beverly Hills, California. The Firm’s Roundtables provide institutional investors from around the globe the opportunity to discuss topics that affect the value of the funds they represent and network with peers in an informal, educational setting.

This year, around 100 attendees traveled to the Roundtable from across the United States, the United Kingdom, France, Italy, and Israel. The theme was the collective power to make change through ESG (environmental, social, and governance), corporate culture and board diversity. Presenters were international experts in the fields of corporate governance, securities litigation, fiduciary duty, ESG priorities, forced arbitration, and board diversity.

According to Pomerantz Partner Jennifer Pafiti, who organized the event, “After having to reschedule numerous times over the past two years due to varying COVID and travel restrictions, the Roundtable coalesced as a highly energized day during which general counsel and corporate governance professionals from some of the largest financial houses around the globe finally had the opportunity to attend in person. Peers came together to learn best practices, with a particular focus on ESG issues, and to share ideas that can really add value to their funds. It was certainly worth the wait!”

Special guest speaker, President Bill Clinton, was interviewed by Pomerantz’s Managing Partner, Jeremy Lieberman, on President Clinton’s time in office, geopolitical issues, and the current global economy.

The panels covered topics of critical importance to the institutional investing community, including “Inside the Boardroom.” The speakers on this panel inspired a lively discussion on how best to engage to address diversity, equity and inclusion (DEI), the conclusion of which was that DEI in the boardroom still has a long way to go.

“Covid-19 and the Litigation Pandemic” addressed ways in which the pandemic has triggered new corporate misconduct, and described cases that are directly derived from companies making misstatements to investors specifically concerning COVID-19.

The “Corporate Governance Developments” panelists engendered vibrant Megan Peitzmeier, Senior Staff Attorney, Colorado PERA “debate among the Roundtable attendees as they explored the global trends in corporate governance and the emerging issues governance professionals will face in the coming year.

Forced arbitration and its negative implications for institutional investors was discussed during one session. The panel of lawyers reported on the Council of Institutional Investors’ and Colorado Public Employees’ Retirement Association’s historic decision to intervene in the Johnson & Johnson action to protect shareholders’ rights against the business community’s push for forced arbitration.

Robert Jackson, Jr., a former Commissioner of the U.S. Securities and Exchange Commission, spoke on “Fiduciary Duty and ESG Priorities in 2022.” The discussion highlighted the limitations of the SEC to deter bad governance in companies, leaving the responsibility to institutional investors to incorporate high standards of ESG performance into their investment analysis and decision-making.

Counsel to a $1.6-trillion European asset management company presented “Securities Litigation Update: Engagement & Litigation.” This session explored institutional investors’ attitudes towards litigation, engagement and other tools used to hold corporations accountable.

At the event’s dinner, attendees heard from the most decorated WNBA player in history, Candace Parker. Candace shared her inspirational journey and achievements and described how she balances a career as a professional athlete with being a full-time mother and businesswoman.

In keeping with the Firm’s continued commitment to provide educational platforms for institutional investors, and in response to the phenomenal feedback from this year’s event, Pomerantz looks forward to hosting the next Roundtable.

“The Roundtable was the perfect size, setting and agenda to ensure that I maximized my time out of the office and completely committed to understanding the corporate governance landscape through the U.S. legal lens. The mix of case studies, frameworks, state, and international perspectives was genuinely insightful to understand the practical crossroads between business, ESG, and law. Each individual session was high quality in its own right, but it was the sum of the parts that left a lasting impression on me.”

Amy D’Eugenio, Director of Business and Client Development for Federated Hermes EOS

If you or your team are interested in attending the next Roundtable event, please register your interest at: PomerantzRoundtable@pomlaw.com.

We extend a hearty thank-you to all our panelists and attendees for making the Roundtable such a success – from all the team at Pomerantz.

Q&A: Tamar A. Weinrib

POMERANTZ MONITOR | JULY AUGUST 2022

By The Editors

Pomerantz Partner Tamar Weinrib’s expert, innovative lawyering has secured court decisions in favor of investors that will form the bedrock of securities litigation for decades to come.

MONITOR: What led you to a career in law?

Tamar Weinrib: From an early age I gravitated toward subjects that foretold a path to a legal career. One of my favorite high school subjects was Talmud. The Talmud is a compilation of oral Jewish laws that are annotated with intricate Rabbinic commentary and discussion covering wide ranging topics. It is without a doubt the first true education I received on legal argument and its foundation in ethics, logic and creativity. Studying the back and forth between Rabbis who held very divergent views on the same topic, the reasoning that led each of them to their views, and the arguments they crafted to persuade others, intrigued me. Though the Talmud dates back centuries, it very much resembles the way that a contemporary lawyer’s mind works. That early study gave me deep respect for legal thought.

The Talmud exemplifies how Jewish law is a living and breathing entity, open to discussion, interpretation, argument, and refinement depending on the circumstances. It may seem like a strange apples-to-oranges comparison, but the same can be said for securities law. The way one applies the law changes significantly depending on the circumstances and facts of each case. No two cases are alike. Circumstances matter, and the facts matter. There is creativity involved in the way that you consider those elements and the right way to apply the law.

M: You mention creativity. How much does that play a role in your practice?

TW: Though I mentioned an early start in my journey toward the legal profession, in college I majored in advertising and minored in art history. To be a successful lawyer, and particularly a litigator, it’s important to have both strong creative and persuasive writing skills, and also to stand in a courtroom and convince your “audience” to see your point of view. Majoring in advertising was solid training in advocacy and oral presentation. Successful advertising involves convincing a consumer to see your product the way you want them to see your product. To be an effective litigator, you have to be able to convince a judge to see the case the way that you want them to see the case.

M: What about the law continues to motivate you?

TW: I am constantly learning. Not just because the securities laws and relevant case law are continuously evolving, but also because each case requires an education into how each defendant company’s industry works. When I led our seminal case against Barclays regarding its “dark pool,” I had to immediately learn about the intricacies of sophisticated, opaque trading platforms that I had never before encountered. We hired a wonderful expert on dark pools to work on the case with us, but there was a lot of self-education. The litigation process itself – research, investigation, reading documents in discovery, asking questions in depositions – all collectively provide a thorough education. It is critical when bringing cases like this to fully understand the underlying industry. I have brought numerous cases against pharmaceutical companies as well. There’s a very intricate FDA approval and clinical testing process before a drug can come to market. So when the underlying claim concerns what a drug company said about the safety or efficacy of its product and how the product was faring during various phases of clinical testing, or, post approval, how it was faring in the market and whether there were reports of serious adverse events – you need to be deeply knowledgeable not just about how the FDA approval process works, but for each case, how the particular drug at issue works.

M: How much of that education occurs before a case is filed?

TW: At Pomerantz, we very carefully investigate our cases before we bring them. So there is a significant amount of research that occurs before the filing of a complaint. We only pursue cases we believe have merit and can only make that determination through “education.” Then, as the case proceeds and we get into discovery, that unpeels the layers of the onion much further.

M: Are there specific challenges to being a woman in law?

TW: What I viewed as challenges when I first started out, I now view as advantages. Especially earlier in my career, I’d walk into a deposition knowing that, given my age and gender, an older male sitting across the table at first glance would have certain expectations and underestimate me. I thrived in challenging those expectations and proving them wrong, and I think that is to my advantage. People don’t always expect a young female attorney to be assertive, to stand her ground or present her case with strength, and it gives me great pleasure to catch them off guard. There can be challenges specific to being a female attorney. But you have a choice – you can see them as challenges, or you can see them as opportunities to prove people wrong and blaze a path that people do not expect you to blaze.

Pomerantz Secures Major Victory for Investors in Case Against Deutsche Bank

POMERANTZ MONITOR | MAY JUNE 2022

By Emma Gilmore

This case has been particularly meaningful to me, given the misconduct at issue — Deutsche Bank’s lending and servicing of Jeffrey Epstein’s accounts — despite knowledge that he sexually abused at least 40 girls.” — Partner Emma Gilmore

Pomerantz clinched a significant victory for investors in a securities fraud class action brought against Deutsche Bank for its false and misleading representations about the Bank’s Know Your Customer procedures—an important aspect of the Bank’s anti-money-laundering processes. On May 18, 2022, Judge Jed S. Rakoff of the United States District Court for the Southern District of New York denied in large part defendants’ motion to dismiss all claims in Karimi v. Deutsche Bank AG, in which Pomerantz serves as sole Lead Counsel.

The complaint alleges that during the relevant Class Period, Deutsche Bank and several of its executives, including its CEO, made materially false and misleading statements about its anti-money-laundering (“AML”) deficiencies and failed to properly monitor or gave exemptions to customers it considered high risk, such as financier and accused sex offender, Jeffrey Epstein. For example, defendants repeatedly assured investors that Deutsche Bank had “developed effective procedures for assessing clients (Know Your Customer or KYC) and a process for accepting new clients in order to facilitate comprehensive compliance,” and insisted that “[o]ur KYC procedures start with intensive checks before accepting a client and continue in the form of regular reviews.” Defendants also claimed Deutsche Bank’s “robust and strict” KYC program “includes strict identification requirements, name screening procedures and the ongoing monitoring and regular review of all existing business relationships,” with “[s]pecial safeguards… implemented for…politically exposed persons.”

In truth, however, far from implementing a “robust and strict” KYC program with “special safeguards” for politically exposed persons (“PEPs”), during the Class Period, defendants repeatedly exempted high-net-worth individuals and PEPs—including unsavory figures like Jeffrey Epstein and individuals sponsoring terrorism—from any meaningful due diligence, enabling their criminal activities through the use of the Bank’s facilities. That practice commenced with Deutsche Bank’s former CEOs onboarding, retaining and servicing Russian oligarchs and PEPs reportedly engaged in criminal activities.

For example, despite widespread coverage of Epstein’s child sex trafficking and abuse, Deutsche Bank’s executives onboarded Epstein as a client in 2013, enabling his criminal activities to not only continue, but also to flourish. In addition to opening and servicing wealth-management accounts for Epstein, Deutsche Bank also provided loans to Epstein and his businesses. Epstein was onboarded based on the lucrative business he would generate for the bank, with Deutsche Bank estimating “flows of $100-300 [million] overtime [SIC] (possibly more) w/ revenue of $2-4 million annually over time….” Despite knowing that by 2011, “40 underage girls had come forward with testimony of Epstein sexually assaulting them,” Deutsche Bank remained “comfortable with things continuing” with Epstein, “not[ing] a number of sizable deals recently.” One of several confidential witnesses with knowledge of Deutsche Bank’s KYC processes explained that, after Epstein was onboarded, decisions about whether to continue keeping him as a client were repeatedly escalated, including to Deutsche Bank’s Reputational Risk Committee and members of Deutsche Bank’s Executive Committee for the Bank’s Global Wealth Management. Despite these warnings, Deutsche Bank repeatedly approved retaining and servicing Epstein. From the time of Epstein’s onboarding, the relationship was classified by Deutsche Bank as “high-risk” and therefore should have been subject to enhanced due diligence. Instead, in a sordid twist of irony, the Bank designated Epstein an “Honorary PEP.”

Defendants made a number of arguments that Pomerantz defeated. For example, defendants argued that Deutsche Bank’s representations to investors about their Know Your Customer procedures were aspirational and immaterial and that, in any event, the investing public was provided with more than enough information to understand the state of Deutsche Bank’s AML and KYC processes (the so called “truth-on-the-market” defense). Pomerantz successfully countered that defendants’ representations were material to investors because, by exempting PEPs and other high-risk individuals from any meaningful KYC procedures, the risk to the Bank’s reputation and the risks of criminal and civil liability were significantly heightened. The materiality of defendants’ statements was also demonstrated by defendants’ repeated discussion of these topics throughout the Class Period. Pomerantz successfully defeated defendants’ “truth-on-the-market” argument that investors knew Deutsche Bank’s AML procedures were not always effective, explaining that such defense on this record was intensely fact-specific and improperly raised at the motion to dismiss stage, particularly given Deutsche Bank’s affirmative representations of compliance made throughout the Class Period.

Judge Rakoff set a trial date for November 2022.

Partner Emma Gilmore, who leads the litigation, said, in response to Judge Rakoff’s decision, “This case has been particularly meaningful to me, given the misconduct at issue – Deutsche Bank’s lending and servicing of Jeffrey Epstein’s accounts – despite knowledge that he sexually abused at least 40 girls.”

Pomerantz Achieves Victory for Defrauded Chicago Bridge & Iron Investors

POMERANTZ MONITOR | MAY JUNE 2022

By Joshua B. Silverman

In a victory for investors, Pomerantz, as counsel for two of the three court-appointed class representatives, achieved a $44 million settlement in a securities fraud class action against Chicago Bridge & Iron Co., N.V. (“CBI”) and its former Chief Executive Officer, Chief Financial Officer, and Chief Accounting Officer. The Honorable Lorna G. Schofield of the United States District Court for the Southern District of New York granted preliminary approval of the settlement on March 30, 2022 and set the final approval hearing for July 25, 2022.

CBI is an energy services company specializing in the engineering, procurement and construction of energy plants and related facilities. In 2013, CBI entered the nuclear fabrication business by acquiring The Shaw Group for $3.3 billion. The crown jewel of the acquisition was Shaw’s nuclear construction unit, which was part of a consortium building the first new nuclear plants in the United States in decades, two at a Georgia facility called Vogtle and two at the V.C. Summer facility in South Carolina. CBI and its CEO claimed to have conducted thorough due diligence prior to the acquisition and to have gained a clear understanding of the status of the nuclear projects.

Between October 2013 and January 2015, CBI and its executives made several positive but false statements about the progress of the nuclear projects, hid adverse information about schedule delays and cost overruns, and claimed in periodic reports filed with the Securities and Exchange Commission that there were no indicators of impairment despite significant internal red flags indicating that the nuclear projects were unlikely to ever yield the profits that the company had modeled. They also misrepresented CBI’s ability to recover for unapproved change orders (“UCOs”)—massive but disputed invoices for expenses stemming from design changes. Although the electric utilities that owned the nuclear projects and CBI’s consortium partner refused to reimburse CBI for the UCOs, CBI nonetheless told investors that payment was probable and booked them as revenue.

In mid-2014, institutional analyst firm Vertical Research and short seller Prescience Point each put out negative reports about CBI’s nuclear construction business. By early 2015, it was clear to CBI (and increasingly to investors) that the nuclear construction business was a disaster. CBI began to negotiate a “quit claim” deal with its consortium partner, Westinghouse, to essentially walk away from the nuclear construction projects, stemming losses but receiving virtually nothing for the business it had paid billions for just two years earlier. In October 2015, CBI announced that it would transfer the nuclear construction business to Westinghouse for only a true up of expenses incurred during the transition.

Early motion practice wins established a momentum that carried plaintiffs to trial. First, plaintiffs defeated defendants’ attempt to transfer the lawsuit to the Southern District of Texas, where CBI would enjoy a “home court” advantage. Then, plaintiffs defeated defendants’ motions to dismiss.

Years of discovery developed strong evidence that defendants had concealed adverse information about the nuclear projects from investors. Pomerantz and other plaintiffs’ counsel reviewed over 9 million pages of documents and took approximately 30 depositions. They uncovered evidence that CBI had manipulated its financial reporting by mixing the nuclear construction business with other profitable businesses into a single reporting unit to hide deterioration and avoid a write-down, that both the owners and Westinghouse had rejected CBI’s view that the contracts required reimbursement of UCOs, and that CBI internally did not expect to be paid on many items booked as revenue for several years, if ever.

In addition to uncovering strong factual evidence, plaintiffs also put together a world-class slate of expert witnesses on the topics of market efficiency, damages/loss causation, accounting, and materiality. These experts were particularly crucial at class certification, where both sides’ economic experts testified during an eleven-hour hearing before the Special Master appointed by the Court, the Honorable Shira Scheindlin (Ret.). Pomerantz played a key role, cross-examining defendants’ expert and exposing the weaknesses in her price impact analysis. The Special Master ruled in a 107-page Report & Recommendation that certification should be granted, which the District Court adopted. After full briefing, the United States Court of Appeals declined to consider an appeal of that ruling.

Unbowed, and despite the considerable evidentiary record amassed by plaintiffs, defendants moved for summary judgment on all claims. After full briefing, the district court denied that motion and set the case for trial in February 2022.

Trial always involves risks, and this one more so than others. Defendants had won a jury trial of similar claims in Texas state court against a hedge fund that opted out of the class action. Although Pomerantz believed that its case did not suffer from the flaws that sunk the Texas case, the Texas trial showed that the risk of an adverse verdict was substantial. Against these risks, the class action plaintiffs had limited upside to proceeding to trial. The corporate defendant and its parent had both declared bankruptcy, and the individual defendants did not have sufficient resources to satisfy a large jury award. While Pomerantz and other plaintiffs’ counsel retained bankruptcy counsel to make sure that bankruptcy releases did not bar class claims, the bankruptcy effectively meant that recovery was limited to a rapidly eroding insurance stack.

Acknowledging the risks that both sides faced at trial, the parties decided to take a final run at mediation before the Honorable Layn R. Phillips (Ret.). Ultimately, both sides accepted a mediator’s proposal to settle the case for $44 million, an excellent recovery under the circumstances. Despite the bankruptcy, Pomerantz’s perseverance resulted in a class recovery that was significantly higher than the median for comparable class actions.

A Case for Statistical Evidence in Insider Trading Claims

POMERANTZ MONITOR | MAY JUNE 2022

By Dolgora Dorzhieva

Insider trading is tough to prove, and it can take years to gather enough evidence to successfully prosecute it. Preet Bharara, the former U.S. Attorney for the Southern District of New York, has called insider trading, undertaken by company insiders and hedge funds, “rampant.” The SEC has developed data analytics tools to aid the investigation of insider trading cases with statistical evidence. However, in SEC v. Clark and Wright, the court rejected the SEC’s statistical evidence as “just a matter of speculation.” On occasion, evidence of insider trading is used to determine whether scienter exists in Rule 10b-5 or securities fraud cases. This article will describe the value of statistical evidence and explain what steps plaintiffs’ lawyers can take to leverage such evidence in prosecuting insider trading claims.

What is Insider Trading?

Insider trading involves trading in a public company’s stock by someone who has material nonpublic information (“MNPI”) about that stock. MNPI is data relating to a company that has not been made public but would have an impact on its share price when made public. Insider trading is often carried out by a group of people rather than by an individual acting alone. Frequently, the person who receives inside information from within an organization (“a tipper”) does not trade on that information, but rather passes information on to others (“tippees”), who ultimately trade based on that information. This type of insider trading is illegal because insiders cannot “misappropriate” information for their own benefit.

Investors may be deterred from participating in the market if they know that others are trading on nonpublic information. However, insider trading violations are difficult both to prosecute and to prove. Often, defendants in insider trading cases will deny their awareness of MNPI at the time of a securities trade, or defendants will claim that their reason for trading was completely unrelated to the information in their possession. Because insider trading involves secret information and communications, it is rare to find a smoking gun proving that a trader was tipped and by whom (i.e., what they knew, when they knew it, and how they found out). Therefore, the government and the plaintiffs’ bar often rely––at least initially––on circumstantial evidence to draw the strong inference that the defendant was aware of MNPI and used that information for personal profit when trading.

SEC v. Clark and Wright and the SEC’s Data Analytics Tools

To aid the investigation of insider trading cases, the SEC has developed numerous data analytics tools for analyzing massive amounts of data to identify suspicious trading, such as improbably successful trading across different securities over time. In SEC v. Clark and Wright, the SEC argued that the trades in question were suspicious because they had “an improbable success rate.” The SEC alleged that Christopher Clark and his brother-in-law, William Wright, the former controller for CEB, Inc., engaged in insider trading in advance of CEB’s acquisition. Based on the information tipped by Wright, Clark allegedly purchased highly speculative, out-of-the money call options. The SEC further alleged that, after the public announcement of the acquisition of CEB for $2.6 billion, Clark liquidated his CEB options and made a profit of over $240,000. The cornerstone of the SEC’s case was “suspicious trading”: Clark and his son purchased CEB’s highly risky options before the merger announcement after Clark maxed out his family’s credit line, took out a loan on his car and liquidated his wife’s IRA account to finance these trades. According to the SEC, Clark and his son “were the only investors in the entire world willing to buy such risky options” and accounted for 100% of the buy-side volume on the days in question. The SEC took the position that Clark’s too-good-to-be-true trades, combined with the fact that Clark borrowed money to make the trades, spent ample time with Wright, and traded after communicating with Wright, clearly pointed to insider trading. Instead of initially presenting testimony or other direct evidence, which is hard to obtain at the outset of insider trading cases, the SEC’s case largely hinged on its statistical surveillance tools’ identification of the trades as “highly suspicious.

Wright settled with the SEC in October 2021. Clark proceeded to trial. Courts have repeatedly held that evidence of suspicious trading that coincides with communications between the alleged tippee and tipper should go to the jury. Judge Hilton, however, ended the SEC’s trial against Clark without hearing Clark’s arguments or allowing the jury to weigh in, finding that the SEC’s statistical evidence was “just a matter of speculation” and that the “improbable success rate” of Clark’s trades was not evidence of anything at all: “the government can speculate that he made a little too much money, he was a little successful or more successful than he ought to be, so therefore he’s getting insider information, but there’s no evidence of it.” Judge Hilton added that “[t]here’s just simply no circumstantial evidence here that gives rise to an inference that he received the insider information.”

The Role of Statistical Evidence in Civil Cases

Is there a qualitative distinction between statistical and non-statistical evidence? According to Judge Posner, “[t]he probabilities that are derived from statistical studies are no less reliable in general than the probabilities that are derived from direct observation, from intuition, or from case studies of a single person or event.” The ambiguity of “statistical” evidence does not differ in kind from the ambiguity of “non-statistical” evidence. The “real problem” of statistical evidence is not the explicit characteristics of the evidence itself; it is instead the interpretation given to that evidence. At its core, evidence takes on meaning for trials only through the process of being considered by an individual. And Judge Hilton’s interpretation of the SEC’s statistical evidence of “suspicious trading” could have been very different from the jury’s interpretation of the same evidence. Moreover, while the use of statistical analysis to identify insider trading is novel, the use of statistical analysis in other fields to provide legal proof is not. Many courts have permitted proof of causation through statistically-based evidence in toxic tort cases, even when the evidence is thin and attenuated, and stronger and better evidence is unavailable. The courts and regulators also rely on statistical analysis to help prove systemic employment discrimination and the efficacy of treatments in clinical trials. This is because the approach employed in statistical analysis of arriving at a conclusion by ruling out plausible alternative explanations is consistent with judicial fact-finding.

The SEC has been very successful in litigating insider trading claims solely on the basis of statistical evidence. For example, in SEC v. Ieremenko, et. al., a case brought against a hacker and several traders who traded on nonpublic information stolen from the SEC’s EDGAR database, the SEC successfully argued that the defendants’ trading was correlated with the EDGAR hacks: “[i]t is virtually impossible that [the suspicious trading] could have occurred by random chance. Statistical analysis shows that for each of the Trader Defendants, the odds of that trader trading so disproportionately in hacked events by random chance ranged from less than 7 in 10 million to less than 1 in 1 trillion. This means that for each of the Trader Defendants, it is nearly impossible that their trading is uncorrelated with the hack of the EDGAR system.”

Thus, it is surprising that the SEC’s case against Clark was dismissed so early. The SEC appealed and, if it prevails, the ultimate legal impact of Judge Hilton’s outlier decision should be minimal. Judge Hilton did not give the SEC a chance to establish evidence of scienter based on strong circumstantial statistical evidence.

An Expert’s Advice for the Plaintiffs’ Bar for Successful Prosecution of Insider Trading Claims

What steps can plaintiffs’ lawyers take to leverage the value of statistical evidence in identifying and deterring wrongdoing in insider trading cases? To find out, I interviewed Daniel Taylor, a professor at The Wharton School of the University of Pennsylvania, who leads the Wharton Forensic Analytics Lab and has done extensive research on insider trading. According to Taylor, a weakness of the plaintiffs’ bar is that it tends to rely on experts who are credentialed law professors not trained in data analysis and visualization. Lawyers don’t understand the power of data and often do not know how to convincingly present statistical evidence to a fact-finder. Taylor says that the plaintiffs’ bar needs a broader expert network for insider trading that includes experts in data analysis and the tools for presenting that analysis to laymen, such as charts and graphs. According to Taylor, there is a lack of visualization within many legal briefs that allege suspicious trading. Taylor says that in an insider trading case, persuasive and compelling evidence would consist of probability calculations and an analysis of counter-factuals. For example, one can highlight an extreme outlier trade by comparing the trade to the distribution of normal trades. Another helpful technique would be to explain the counter-factual: for example, as it was with Clark, it is exceptionally rare for an individual to liquidate their retirement accounts, max out their credit lines, take out an auto loan, and risk those proceeds investing in out-of-the-money options unless the individual knew they had MNPI.

COVID-19 and the Litigation Pandemic

POMERANTZ MONITOR | MAY JUNE 2022

By The Editors

In January 2020, as the novel coronavirus spread globally and the death toll rose, so too did peoples’ fears. While many companies diligently shared information about their new risks with shareholders, others sought to profit from the widespread anxiety. On March 12, 2020, one day after the World Health Organization declared the novel coronavirus to be a pandemic, the first COVID-19-related securities class action lawsuits were filed. Each of these litigations is representative of a separate trend in subsequent securities class actions related to COVID-19: cases that target industries, such as pharmaceuticals, whose products are involved in responding to the coronavirus, and cases that target industries that the virus directly affected, such as cruise lines.

One of the two securities class actions filed on March 12, 2020, targeted Inovio Pharmaceuticals, Inc. (“Inovio”) and its CEO, J. Joseph Kim. Kim, in two public appearances in February 2020 – one on Fox Business News and one with President Trump – claimed that Inovio had already developed a COVID-19 vaccine and would start phase one testing in the early summer. Inovio’s stock price skyrocketed amidst a buying frenzy – that is, until Citron Research disclosed that Inovio did not, in fact, have a viable vaccine. Subsequently, the company was forced to acknowledge that it had merely “designed” one. According to the complaint, that disclosure led to a two-day drop in Inovio’s share price that “wiped out approximately $643 million in market capitalization for the Company, marking a 71% decline from its Class Period high.”

The second COVID-19-related securities action filed on that day sued Norwegian Cruise Line Holdings (“NCL”) on behalf of a proposed class of shareholders who had purchased shares of the company during the three weeks before the pandemic was declared. On February 20, 2020, NCL issued a press release stating that “despite the current known impact” from the coronavirus outbreak, as of the week ending February 14, 2020, “the Company’s booked position remained ahead of prior year and at higher prices on a comparable basis.” In other words, they had plenty of ticketed passengers and NCL was still planning on setting sail with them. It further stated that the company “has an exemplary track record of demonstrating its resilience in challenging environments” and that NCL had “proactively implemented several preventive measures to reduce potential exposure and transmission of COVID-19.”

The complaint alleged that these statements, as well as others in the company’s SEC filings published concurrently with the press release, were false and misleading. The complaint quoted a Miami New Times article that reported that leaked internal NCL emails demonstrated that the company had pressured its sales teams to mislead customers about the coronavirus and to respond to customers’ concerns by suggesting, among other things, that the virus could not survive in warm Caribbean climates. The article further reported that while news of the coronavirus was dramatically reducing cruise bookings, management was “trying to downplay the disruption in sales at all costs.”

The Securities and Exchange Commission (“SEC”) gave initial COVID-19 guidance to companies when, on April 8, 2020, its Chairman, Jay Clayton, and Director, Division of Corporation Finance, William Hinman, issued a joint statement titled “For Investors, Markets and Our Fight Against COVID-19.” They stated that company disclosures should “respond to investor interest in: (1) where the company stands today, operationally and financially, (2) how the company’s COVID-19 response, including its efforts to protect the health and well-being of its workforce and its customers, is progressing, and (3) how its operations and financial condition may change as all our efforts to fight COVID-19 progress. Historical information may be relatively less significant.”

Inovio and Norwegian Cruise Line: The Rulings

In February 2021, the court largely upheld the Inovio plaintiffs’ claims described above; the case is ongoing.

As for Norwegian Cruise Line, on April 10, 2021, Judge Robert N. Scola, Jr. of the Southern District of Florida granted NCL’s motion to dismiss with prejudice. As Kevin M. LaCroix posted on the D&O Diary on April 12, 2021 “Judge Scola seemed comprehensively skeptical of the plaintiff’s case.” The judge held that the statements at issue were protected by the “safe harbor” provision for forward-looking statements of the Private Securities Litigation Reform Act of 1995. This provision encourages companies to provide projections of future financial results and other forward-looking statements, so long as such statements are identified as forward-looking and accompanied by strong cautionary disclosure about factors that could cause actual results to differ materially from those disclosed in the statements.

Judge Scola also held that, as to the alleged marketing scheme to downplay the impact of the coronavirus, plaintiff made the assumption “that at the time these statements were made, the statements were false,” but the Judge wrote that “it is worth noting that at the time the alleged marketing scheme was taking place, then-President Trump made similar statements regarding COVID-19 and therefore it is arguable that these statements were not even deceptive, insofar as they aligned with the pronouncements of our nation’s President.”

Lest some are tempted to speculate on Judge Scola’s political leanings, given his reliance on President Trump as an arbiter of truth, the Monitor would like to point out that the judge was appointed by President Obama.

The Trajectory: Then to Now

Early COVID-related securities actions focused on companies that relied on misrepresentation to increase share price and insufficient risk disclosures prior to the pandemic. Years later, these continue to be central to many complaints. The initial cases primarily targeted companies that the virus directly impacted, such as pharmaceutical companies and cruise lines. As allegations broadened to include challenges to companies’ representations about how the pandemic impacted projections of future financial performance and consumer behavior, so too, the types of industries targeted by securities lawsuits expanded. Technology companies, manufacturers of pandemic-related products, travel companies, finance, utility, and social media companies have all been sued for violations of the federal securities laws. The Securities and Exchange Commission (“SEC”) has stepped in to address COVID-19 related fraud with enforcement actions. Derivative cases stemming from COVID-19 securities class actions have been filed against directors of corporations for inadequately fulfilling their fiduciary duties during the pandemic.

On January 26, 2022, Pomerantz was appointed co-lead counsel in a putative securities class action lawsuit against biotechnology company, Novavax, Inc., arising from Novavax’s statements made in connection with its failed attempt to bring its COVID-19 vaccine candidate, NVX-CoV2373, to market. Plaintiffs allege that Novavax misled investors about the vaccine’s purported successful development, production, and imminent approval by the U.S. Food and Drug Administration (“FDA”). “In reality,” according to the complaint, “Novavax’s vaccine was nowhere close to being approved for use: (a) because the vaccine’s purity and potency numbers fell well below FDA safety requirements as a result of severe manufacturing problems including several undisclosed contamination events at its two U.S. manufacturing facilities; (b) because of a failure to manufacture the vaccine at scale; and (c) because of supply chain disruptions—all of which caused significant delays that jeopardized any chance Novavax had to capitalize on the market for Covid-19 vaccines.”

A series of partial disclosures, beginning on May 10, 2021, revealed problems with NVX-CoV2373, including manufacturing issues and delays with its application for Emergency Use Authorization from the FDA. Finally, on October 19, 2021, Politico published an article entitled “They rushed the process: Vaccine maker’s woes hamper global inoculation campaign.” The article reported that Novavax “faces significant hurdles in proving it can manufacture a shot that meets regulators’ quality standards” with respect to NVXCoV2373” and cited anonymous sources as stating that Novavax’s “issues are more concerning than previously understood” and that the company could take until the end of 2022 to resolve its manufacturing issues and win regulatory authorizations and approvals.

Pomerantz is vigorously fighting to vindicate defrauded Novavax shareholders’ rights and recover their losses caused by fraud.

The Fourth Circuit Raises the Bar for Plaintiffs Pleading Scienter

POMERANTZ MONITOR | MAY JUNE 2022

By Christopher Tourek

A core pillar in many securities’ fraud actions is scienter – i.e., whether a defendant acted with an intent to deceive, manipulate, defraud, or was severely reckless, which is defined as carelessness so unreasonable that it risked misleading shareholders. To make it past the motion to dismiss stage, plaintiffs are required to allege sufficient facts to establish that the likelihood of fraudulent intent – the inference of scienter – is at least as strong as the likelihood of any non-fraudulent explanation for a defendant’s actions. The Court of Appeals for the Fourth Circuit recently addressed the issue of which elements must be pled to establish scienter in a securities fraud case and, in doing so, highlighted the uphill battle that plaintiffs face in sufficiently pleading scienter to survive a motion to dismiss.

As set forth in In re DXC Technology Company Securities Litigation, DXC issued a press release touting its financial success, but months later, the company revised its projected revenue downward by approximately $800 million, causing the company’s share price to drop. Plaintiffs subsequently brought suit against DXC and its executives, alleging that they knew, contrary to DXC’s press release, that cost-cutting measures in 2018 would impede the company’s ability to draw revenue. The District Court for the Eastern District of Virginia dismissed the complaint, and the plaintiffs appealed that decision to the Court of Appeals for the Fourth Circuit.

The Fourth Circuit affirmed the District Court’s dismissal of the stockholders’ claim of securities fraud and, in doing so, analyzed the five different categories of scienter that the plaintiffs relied upon. Specifically, to determine whether the requisite scienter existed, the Fourth Circuit analyzed (1) statements of unnamed former employees, (2) the core-operations theory, (3) allegations by a former executive, (4) stock sales made by the defendants, and (5) the temporal proximity between the defendants’ optimistic statements and the ultimate admission of disappointing revenue. In ruling against the plaintiffs, the Fourth Circuit discounted most of the plaintiffs’ allegations on which they premised scienter and, in doing so, emphasized the high bar that plaintiffs must meet to make it past a defendant’s motion to dismiss.

The Fourth Circuit first reviewed the statements of unnamed former employees to the effect that they were concerned about the cost-cutting measures. There, the Fourth Circuit found that, by and large, the former employees had little or no contact with the defendants and did not pass along their concerns to the defendants. This, combined with the fact that the few times employees did notify the defendants of their concerns were described by the complaint in a vague and conclusory fashion, led the Fourth Circuit to discount this factor. Thus, plaintiffs who rely on statements of former employees in the future will need to make sure that those employees had direct contact with the defendants and describe those interactions with particularity.

Similarly, the Fourth Circuit discounted the plaintiffs’ core operations theory because, as with the statements of former employees, the complaint lacked “particularized allegations” regarding the defendants’ knowledge of the shortcomings due to the cost-cutting measures.

The Fourth Circuit also analyzed the plaintiffs’ claims that a former executive told the defendants that cost-cutting measures could impede revenue. The Fourth Circuit found that the defendants were never alleged to have agreed with the former executive and therefore this could be chalked up to a simple disagreement among executives, negating any inference of scienter. Significantly, the Fourth Circuit’s analysis makes clear that for plaintiffs to effectively plead scienter, they must allege that not only were defendants aware of concerns that their statements to investors were false, but also that they agreed with those concerns.

The Fourth Circuit’s discussion of stock sales by the defendants should similarly raise concern for plaintiffs who are filing a securities fraud action. In its opinion, the Fourth Circuit found that while one defendant sold 77% of his stock during the class period, he also sold more stock before the class period. Thus, according to the Fourth Circuit, despite the massive amount of stock sold during the class period, if a defendant sells less stock during the class period than before it, scienter is unlikely to be found. Concerning the other defendant, while he sold no stock before the class period, the Fourth Circuit found that he only sold 17% of his stock (amounting to approximately $10 million) during the class period, which was de minimis. The Appellate Court also noted that the plaintiffs failed to explain why the defendant selling 17% of his holdings was not de minimis. Thus, due to the plaintiffs’ failure to address the de minimis issue in their briefing, a defendant’s sale of 17% or less of stock during a class period is unlikely to raise the spectrum of scienter.

Even more concerning for potential plaintiffs was the Fourth Circuit’s notice of the defendants’ 10b5-1 trading plans in its analysis. While the Fourth Circuit recognized that the record is silent about when the defendants entered the plans (and thus cannot say whether the plans mitigate a suggestion of motive) and that 10b5-1 trading plans are effectively affirmative defenses that should not be considered at the motion to dismiss stage, the Appellate Court still considered them in its analysis of the defendants’ stock sales and held that the plans “weaken[s] any inference of fraudulent purpose.” Thus, despite itself acknowledging that there is no evidence to show that the defendants entered into the trading plans after the class period began or that it should not be considering the trading plans at all on a motion to dismiss, the Fourth Circuit still used them to discount any inference of scienter from the defendants’ stock sales. The holding of the Fourth Circuit warns potential plaintiffs that they must carefully examine the stock sales of defendants before and during the class period, as well as thoroughly attack any use by defendants of 10b5-1 trading plans to weaken an inference of scienter.

Finally, the Fourth Circuit considered the temporal proximity between the defendants’ allegedly false statements and the subsequent disclosure of truth and found that while the three-month gap between the rosy picture painted by the defendants and the truth of falling revenue was relevant, it alone could not establish a strong inference of scienter. Ultimately, after discounting most of the plaintiffs’ allegations of scienter, the Fourth Circuit held that, under a holistic analysis, the non-fraudulent inference was more compelling than the requisite inference that the defendants knowingly or recklessly misled investors about the company’s financial health.

While the full implications of the Fourth Circuit’s opinion are yet to be seen, the opinion outlines a difficult road ahead for plaintiffs trying to plead scienter. Moving forward, plaintiffs would be wise to learn from the failings of the DXC plaintiffs and plead their complaints with the particularity and detail that the Fourth Circuit found lacking, address both a defendant’s stock sales and any 10b5-1 trading plans – irrespective of whether they should be considered on a motion to dismiss, and work to find evidence that a defendant not only heard evidence that their statements were misleading, but agreed with that evidence.

Q&A - Christine Simmons

Chief Operating Officer, Academy of Motion Pictures Arts and Sciences

POMERANTZ MONITOR | MAY JUNE 2022

Partner Jennifer Pafiti: You are the first African American and woman to serve as COO for the Academy and you lead its first Office of Representation, Inclusion, and Equity. What do these firsts mean for you and for the motion picture industry?

Christine Simmons: My perspective on firsts has evolved. There always has to be a first. But now I ask, “Why has it taken so long?” We have to reflect back on the system, the organization, and the various industries, and really analyze the ‘whys.’ Why is there only one? What can we do systematically to create more opportunities? Until we look at some of the systematic constructs that affirm or even recreate inequities, then we will continue to have them. Vice President Kamala Harris said, “I may be the first woman to hold this office. But I won’t be the last.” If that happens, then that means that we failed. I don’t want to be the best Black COO. I don’t want to be the best female anything. I just want to be the best me, period. The challenge is acknowledging the inequities that exist because it is not an equal race, period. We have a responsibility here in the film and TV business, and in entertainment in general, to make sure that we’re putting forward images that show people that they can break the mold and be so many different things.

JP: What is the next step for the Academy in regard to DEI?

CS: Keep going, go deeper, go farther, go faster. The Academy is turning 95 this year. You can imagine that helping your 95-year-old grandfather evolve and learn new things is quite the challenge, right? So, from year zero to #OscarsSoWhite, the runway keeps getting shorter, and the need to make change is getting more urgent. Little bite-sized changes are no longer enough. But we can’t just blow up the system. Some of it is good, so let’s figure out how we can break those institutionalized constructs that have continued to reaffirm inequity. After #OscarsSoWhite, our goal was to double the number of women and double the number of people who identify in historically underutilized ethnic or racial communities by 2020. We met and exceeded those goals, in addition to adding some board seats. The challenge with diversity is, if you’re only counting numbers, it doesn’t help people understand the “why.” And if you don’t have the common language and vocabulary and understanding of ideologies that create inequities, you look at it as an attack. We want to make sure that all of our allies are coming along with us to help understand that diversity actually enhances the art form. A big step is the launch of our inclusion standards around Best Picture: If you are interested in submitting your film for Best Picture, then you will need to meet two of four diversity standards. We want to make sure that it’s not limiting or censoring in any way. Our initiative is to broaden the aperture through which excellence is recognized. Because if you’re only looking at your aperture in one place, then you’re missing all this beautiful excellence everywhere else. We’re also looking at supplier diversity, our marketing spend, and our investment portfolio. Our investment committee has directed significant dollars to diverse portfolio managers, which I’m extremely proud of. And those are just some of the behind-the-scenes actions that folks aren’t even aware of, but we know that the ripple effect helps.

JP: What mistakes do even well-intentioned companies make in their diversity plans?

CS: One of my dear friends was chair of OB-GYN at a major hospital. The hospital kept setting meetings at the exact time she had to drop her kids off at school in the morning. Her experience as a working mother was not being heard. That’s why it’s important to have different perspectives on the female-lived experience or the Latino-lived experience in that case because there are aspects of that lived experience that you could study in a book or see on TV, but without living it, you can’t fully understand and account for it in the way you manage your staff. Wanting the numbers, wanting it reflective of the population is beautiful, we love that. But if you don’t create a community, a village, and a safe space where people can feel heard and valued, then it actually sometimes can be worse than if you didn’t bring them in at all. If you feel like you’re constantly demeaned or you’re constantly pushed aside or you’re mansplained, then the numbers don’t matter. There’s a whole revolution happening in corporate culture right now in which, if you don’t have an empathetic ear, if you’re not a servant leader, you’ll find your people joining the Great Resignation. Leaders need to pause for a second to figure what’s going on in this person’s life. And that way, they can hopefully find ways to inspire and motivate and empower their people. When that happens, the organization is always better off.

JP: If an organization takes just one step toward diversity, what should that be?

CS: I would start with education. We all have to understand each other and have a common language. It really starts with ideologies and understanding the difference between ideological oppression, institutionalized oppression, internalized oppression, and interpersonal oppression. People tend to think things are the way they are because that’s just how it always was. Well, there’s a reason why it was that way. Our unconscious bias trainer tells a story about a fish just swimming in the water, not even knowing that the water exists because that’s its life. In that way, a lot of the sexist, racist, and other negative ideologies are just water that’s around us and we don’t even realize it, because we’ve just been in it our whole lives. Stopping the automaticity of the ideologies that we have been swimming in is important for helping people understand. When you think of a CEO, people think of white men. When people think about a convict, they think of black or Latino men, right? They don’t think of maybe an affluent white-collar criminal, and we know some notable ones! Ideologies, education, and building a common vocabulary, start there. Then start looking at the systems.

JP: Can you foresee a time when DEI programs won’t be necessary?

CS: No. But I’m a hopeless idealist and optimist, so I think the beauty is, and my hope and prayer is, that eventually, it goes from fixing the systems to getting to celebrate diversity. What does that look like? I’m about to march in my first Pride Parade, walking next to my brothers and sisters in the LGBTQ community, and we’re going to have a great time. I’m going to celebrate them in their life and in their love. Even though I’m not a member of that community, I get to celebrate them. For me, that’s what it looks like. In regards to racism, folks often talk about being colorblind. Colorblind is beautiful, in its ideology and in theory, but when you turn a blind eye to something, then you make it invisible. We don’t want to make anything invisible; we want to celebrate it.

JP: You have said that you like to inspire people to be their best selves. What is the most effective way to do that?

CS: It starts with just being present and listening. People want to be seen, first and foremost, they want to know that you’re present, that you’re listening, that you care. So, to actually be there is important. And, more importantly, I want everyone to feel as joyful as I feel, as beautiful as I may feel in that moment. And I truly mean it from the inside. Like, that self-love and joy from the inside that makes someone glow. I like to pull that out of people. I want to listen to what they want to do, and then help push them forward and help them live their dreams. Just one conversation can literally change someone’s life because they may not know what type of career they want. That conversation may expose them to a whole other world – a job or a path or a choice that they never knew existed.

JP: You are a volunteer for Brown Girls Dream. What advice do you give to young leaders of color?   CS: One of my besties, Cari Champion, a broadcaster, producer and phenomenal woman, tapped into all of her besties in the entertainment and sports businesses, like Jemele Hill (The Atlantic Contributor and Host of Unbothered), Bozoma Saint John (Hall of Fame Marketing Exec), Nischelle Turner (5x Emmy-winning host of Entertainment tonight and a Producer) and myself, to mentor young 20-somethings who aspire to similar careers. And it’s been great. I get three to four mentees a year. They come to us for career advice and guidance. What I’m loving most is seeing the network they’re creating amongst themselves. What we do is really a level beyond mentorship – it is sponsorship because we have actually hired many of the extraordinary women within our various organizations. We’re removing many of the roadblocks that we had to face so they can get here faster, with less pain, drama, and trauma, so they can make an even bigger impact. One of the hardest lessons that young leaders and executives have to learn is that as you go up, as you become more successful, we have to solve multiple people’s problems and multiple organizational problems. And so, we help them navigate all of that to show them the different perspectives through our lived experiences.

JP: From YMCA Visionary to Ebony’s Power 100 list and being touted as one of LA’s most influential people, you have received many accolades. Is there one accomplishment that makes you proudest?

CS: Honestly, all of those make me really proud. But there was a time, around the time Hillary was running for president – it was actually the night before – and I was watching and very stressed. My son was like, “Mom, what’s wrong?” He was five or six at the time, and I had started working at Sparks when he was about three. So, I told him that tomorrow we might have our first female president. Now, mind you, I’m a single mom, so I had been taking him with me to the games and to board meetings of the UCLA Alumni Association when I was president. And he would just sit in the corner at all of the work events and watch. So, he said, “But Mom, you’re a president.” And in that moment, first – I had tears. Second – it was mom for the win, right? Because there was so much guilt with sometimes having to parent in front of 10,000 fans at Staples Center because I needed to bring him with me. There was guilt when I saw my boss and I had my son on my hip. Then I thought – Look, you run this organization, Christine, you have to set the tone. You have to tell people, it’s okay. I just had to shift my mentality and not worry about that. Moms know how mom guilt works – you have a late meeting and they’re asking “Mom, are you coming home?” but you can’t be there all the time. They don’t mean to make you feel bad, but they just miss you. So, when he said that, I thought – exposure works! One of the things that I think as a society, we don’t do enough, is expose. He’s been exposed to women presidents in all areas of life, so why wouldn’t one be President of the United States, right? I think it’s that if we expose young men and young girls to all of this more often, then we’ll be in a much better place. So, for me, yes, those awards are phenomenal and they’re affirming but I think more about the impact that we’re making for the next generation. And, that night, that did it for me. So that’s most important.

SPAC Attack: How Pomerantz and the SEC Are Tackling SPAC Liability

POMERANTZ MONITOR | MAY JUNE 2022

By James M. LoPiano

By now, many investors are aware of that recently trending phenomenon, the Special Purpose Acquisition Company, or “SPAC” for short. However, investors may confuse going public via “de-SPAC” transactions, whereby a SPAC takes a private company public, as equivalent to traditional initial public offerings, or “IPOs.” Others may be unaware that SPACs first conduct their own IPO before taking other companies public.

IPOs and de-SPAC transactions are subject to very different rules, and holding SPACs, and companies formed by de-SPAC transactions (“de-SPAC companies”), accountable in connection with IPOs and de-SPAC transactions may prove more complicated than holding other companies accountable in connection with IPOs. Recognizing this, both Pomerantz and the SEC have been formulating their own ways to harmonize SPAC-related liabilities with traditional IPO liabilities.

Most investors are familiar with the idea of a “traditional” IPO, whereby a private company, supported by underwriters, satisfies certain conditions to begin publicly trading on a national securities exchange at a pre-determined initial offering price. For example, take a hypothetical private company called “XYZ Corp.” that conducts an IPO and thereby first begins publicly offering its shares to the public under the ticker symbol “XYZ” at an IPO price of $10 per share.

Recently, however, private companies have increasingly gone public through business combinations with SPACs, also called “blank-check companies,” which are development stage companies that have no operations of their own, apart from looking for private entities with which to engage in a merger or acquisition (called “target” companies) to take the target public. The SPAC has already gone public via its own IPO in this scenario and, indeed, a SPAC usually touts its management’s ability to identify and merge with potentially lucrative targets in the registration statement for its IPO.

So, what does a de-SPAC transaction look like? Let’s assume a hypothetical SPAC called “ABC Company” recently went public via an IPO. Individuals invested in ABC Company’s IPO on the understanding that its management have expertise in identifying targets and conducting due diligence in selecting and closing mergers with those targets. ABC Company then identifies several targets looking to go public, including our hypothetical XYZ Corp., and agrees to take XYZ Corp. public. ABC Company then merges with XYZ Corp. and, in the process of doing so, changes its name and business operations to XYZ Corp.’s name and business operations (or something similar), issues new shares under a new ticker symbol reflecting its new identity (for example, converts “ABC” shares to “XYZ” shares), and some or all of XYZ Corp.’s management starts running the newly combined company. In our hypothetical, XYZ Corp. has essentially “gone public” through the already-public ABC Company’s transformation into, essentially, what was XYZ Corp.

In this way, SPACs are like shapeshifters or doppelgangers; they are publicly listed blank slates waiting to take on the persona, business operations, and executive teams of private companies. However, these de-SPAC transactions present their own issues that individuals may be unaware of when investing in the post-merger de-SPAC company or pre-merger SPAC.

When individuals lose money on their investments in IPOs, they may seek relief under the federal securities laws through a strict liability claim under Section 11 of the Securities Act of 1933. Under Section 11, public companies can be held strictly liable in connection with material misstatements or omissions made in the IPO’s registration statement—which is required to register new shares and conduct the IPO—so long as the Section 11 claim is brought within a time limit set by the law. When investors purchase shares pursuant or traceable to an IPO’s registration statement, they typically show a loss on their investment for Section 11 purposes by comparing the share’s IPO price to its current trading price.

In the context of a SPAC IPO or de-SPAC transaction, however, it can be difficult to identify whether the original security is trading below its initially offered price. Why? The answer depends on whether you are bringing a Section 11 claim based on the SPAC’s IPO, or the de-SPAC transaction.

Shares offered in a SPAC’s IPO, usually called units, typically become stock and warrants that eventually list under different ticker symbols at different prices. Additionally, the SPAC’s securities (unit, stock, warrant, or otherwise) will typically convert into shares of the de-SPAC company following the de-SPAC transaction. Under both scenarios, shares purchased pursuant or traceable to the SPAC’s IPO may not be listed anymore, so it becomes difficult to know what their current market value is and to compare that value to the IPO price for purposes of Section 11.

De-SPAC transactions present their own issues simply because, unlike IPOs, they often do not have an IPO price or other formally, predetermined, easy to identify initial trading value to compare to current market values.

In bringing SPAC cases to the courthouse, Pomerantz has formulated several potential solutions to these problems. For example, if an investor wants to bring a Section 11 lawsuit in connection with shares purchased in a SPAC’s IPO (let us say they are units), and the units no longer trade, so there is no current unit price to compare to the IPO price, you might allege liability by seeing whether whatever the units transformed into—stock, warrants, or otherwise—are trading so far below the unit’s IPO as to be reasonably certain that you lost money on your investment.

On the other hand, if an investor wants to bring a Section 11 lawsuit in connection with shares purchased in a de-SPAC transaction, and they see that the shares purchased in the de-SPAC transaction are trading low, but there is no IPO price, per se, to compare it to, the investor might allege liability by substituting a formal IPO price for the de-SPAC company’s first publicly listed closing price.

Moving beyond strict liability claims under Section 11 of the Securities Act, an investor may opt to allege securities fraud claims under Section 10(b) of the Securities Exchange Act of 1934. Although more difficult to allege, in this scenario an investor might argue that the SPAC and its management knowingly overstated their expertise and due diligence efforts in identifying and acquiring a target company. Alternatively, investors might argue that the target company and its management knowingly hid issues from the SPAC or the public when announcing it would go public via a de-SPAC transaction.

Additionally, somewhat like a Section 11 claim under the Securities Act, there is a Section 14(a) claim under the Exchange Act, which investors can bring in connection with material misstatements or omissions made in a merger’s registration statement. Here, too, there may not be a formal IPO or other predetermined listing price for new shares created in a merger for a de-SPAC transaction, so one might compare the de-SPAC company’s current trading price to its first publicly listed closing price to allege liability.

The SEC, on the other hand, has proposed sweeping rule changes for SPACs that, if adopted, could better align de-SPAC transaction liability with traditional IPO liability. As noted by The National Law Review, these proposed rule changes cover six broad areas: (1) specialized SPAC disclosure requirements; (2) aligning de-SPAC transactions with traditional IPOs; (3) business combinations involving shell companies; (4) increased projections disclosures; (5) Investment Company Act safe harbor for SPACs; and (6) fairness of the de-SPAC transaction.

One such rule could effectively end protections afforded to companies under the Private Securities Litigation Reform Act of 1995 (“PSLRA”) when making forward-looking statements accompanied by meaningful cautionary language in connection with de-SPAC transactions. These safe harbor protections essentially boil down to companies and management disclaiming liability for positive statements made about potential future projections, earnings, results, plans, etc. (hence, “forward-looking” statements) when paired with adequate warnings about the certainty of these events occurring. Companies provide safe harbor warnings in many contexts, including earnings releases, quarterly reports, and even investor calls. The SEC’s proposed rule changes would modify the definition of a “blank check company” for the purposes of the PSLRA to include SPACs, and the PSLRA bars such safe harbor from applying to forward-looking statements made in connection with traditional IPOs or securities offerings by blank check companies.

Another example of rules aimed at harmonizing de-SPAC transaction liability with IPO liability includes a proposal that would amend registration statements issued in connection with de-SPAC transactions. Under this rule change, the target company would have to sign as a co-registrant on the registration form filed by the SPAC for the de-SPAC transaction. Additional signatories could include the target company’s principal executive officer, principal financial officer, controller/principal accounting officer, and board members, who could then be held strictly liable under Section 11 of the Securities Act for any material misstatements or omissions in the registration statement.

As stated by SEC Chair Gary Gensler, “Functionally, the SPAC target IPO is being used as an alternative means to conduct an IPO. Thus, investors deserve the protections they receive from traditional IPOs, with respect to information asymmetries, fraud, and conflicts, and when it comes to disclosure, marketing practices, gatekeepers, and issuers.”

Although Pomerantz and the SEC are using different government branches to tackle these issues—for Pomerantz, the courthouses of the judicial branch, and for the SEC, the rule-making process of the executive branch—both are working to harmonize SPAC-related liabilities with traditional IPO liabilities. All the same, investors should avoid confusing IPOs with de-SPAC transactions and remain aware of the foregoing issues when deciding to invest in either SPAC IPOs or de-SPAC transactions.

Free Speech vs Corporate Lies: The Role of the First Amendment in Securities Fraud

POMERANTZ MONITOR | MARCH APRIL 2022

By Villi Shteyn

The intersection of fraud and claimed free speech protection under the First Amendment is fraught with controversy. From defamation to fraud, obscenity, hate speech, and even fighting words – the fine line between protected and prohibited speech is left largely undefined by guidelines from the bench that sometimes fail to go beyond “you’ll know it when you see it.” Add commercial speech and the complexities of securities fraud class action litigation into the debate and you have what James C. Goodale – famed General Counsel who represented The New York Times in their Sullivan and Pentagon Papers cases – described as a “collision course” between the First Amendment and securities regulation. Goodale asserted that “there is no greater statutory regulation of speech than the ‘33 and ‘34 Securities Acts and the ‘40 Investment Adviser and Investment Company Acts.”

A recent case involving oil giant ExxonMobil Corp. (“Exxon”) shows how bad faith misuse of the First Amendment can threaten investor protections. In a recent appeal in Massachusetts state court, Exxon argued that Massachusetts Attorney General Maura Healey’s suit under the state’s consumer protection statute should fail because Exxon’s public statements (and alleged omissions) relating to climate change were protected under the First Amendment of the United States Constitution. Exxon claimed the statements, rather than being targeted at consumers and investors, were directed at policymakers and the public at large to influence energy policy, thus fitting into the statutory definition of “petitioning.” Exxon argued that, due to its position as a large energy company, it must take an active role in the public discussion on energy policy, and these statements are protected so that it can fulfill that role.

Suffolk Superior Court Justice Karen Green did not find Exxon’s arguments convincing and denied dismissal of the suit. Justice Green found that Attorney General Healey’s claims that Exxon lied to consumers by marketing its products as environmentally friendly could move forward, as could claims that Exxon misled investors by downplaying any climate-driven financial risks to its bottom-line financials. Significantly, Justice Green found that commercial speech is protected under the First Amendment if the speech concerns lawful activity and is not misleading, but not when it includes fraudulent statements. Given the allegation of fraud to consumers and investors, she held that First Amendment protection was not warranted at the motion to dismiss stage.

On appeal, Exxon has argued that “[b]y premising its claims on Exxon’s advocacy and alleged omissions regarding preferred policies on climate change, the Commonwealth seeks to curtail Exxon’s exercise of its right of petition by punishing Exxon, through litigation, for not propounding a particular message.” Exxon further claims that climate change is one of several controversial and sensitive topics of public concern, and due to that, forcing any disclaimers to accompany Exxon’s statements regarding the matter to prevent allegedly misleading omissions is compelled speech on issues of public concern, and an unconstitutional step by the Commonwealth of Massachusetts to take. It further argues that this is simply “a policy disagreement about the potential scale and efficacy” of certain alternative energy sources. Exxon also claims that the Commonwealth’s views on what constitutes good or poor energy policy should not form the basis of forcing the company to disseminate opposing viewpoints on the matter or otherwise subject itself to liability. This, according to Exxon, creates a chilling effect on petitioning activity vis à vis the First Amendment.

The Massachusetts Attorney General responded that the intended audience was very clearly investors and consumers; Exxon’s statements were commercially motivated and profit-oriented, rather than petitioning the government. Exxon’s claims of petitioning, according to the AG, are a phony pretext for its actual goal for the statements, and its First Amendment defense is a delay tactic used by defendants in similar cases. Additionally, the Commonwealth of Massachusetts had the clear goal of protecting investors and consumers, not punishing Exxon due to disagreements with its climate change policy viewpoints.

Some examples of representations clearly made to investors were that Exxon will “face virtually no meaningful transition risks from climate change.” In Exxon’s 2018 Energy Outlook, the company told investors that it “use[s] the Outlook to help inform ... long-term business strategies and investment plans.” According to the AG, these statements plainly target investors and should not be shielded from liability under the contrived premise of free speech. The Commonwealth further pointed to the fact that Exxon itself described their communications as “branding and marketing efforts,” “corporate messaging,” and “statements highlighting the positive features of its business.” Plainly, the Commonwealth argues, they aim to deceive investors about the significant and existential threat that climate change poses to the company’s value. The appeal is currently pending in the Massachusetts Supreme Court.

Exxon’s line of reasoning certainly raises concerns in the context of securities fraud actions, although, in a good sign to investors, courts have been similarly unconvinced in that context in several recent cases. One example is in a recent major victory for Pomerantz in the Altria and JUUL securities fraud litigation in the Eastern District of Virginia. The court there, in a 2021 opinion, found that the Noerr-Pennington doctrine, which is meant to safeguard the First Amendment right to petition the government for a redress of grievances by immunizing liability that may attend the exercise of that right, did not call for the dismissal of plaintiffs’ claims related to defendants’ statements made to Congress – in this case, Altria and Juul’s denials that they marketed their nicotine vaping products to children – because “the First Amendment offers no protection when petitioning activity ... is a mere sham to cover an attempt to violate federal law.” The court found that plaintiffs’ fraud allegations under the Exchange Act raised the sham exception, and, in any event, the doctrine was an affirmative defense that could not be decided at the motion to dismiss stage. Thus, even if speech was established as petitioning, First Amendment protection does not apply when the speech is used to fraudulently deceive investors.

A 2020 Northern District of California court opinion found similarly against Apple in a securities fraud action against the company concerning allegations that processing performance was intentionally throttled on iPhones. In this case, the court denied the Noerr-Pennington First Amendment defense because Apple could not show that it was seeking any redress from policymakers implicating their First Amendment rights, despite the speech in question being a letter to Congress.

In 2003, in Nike, Inc. v. Kasky, the argument for First Amendment protection for corporate speech reached the United States Supreme Court, as Nike fought allegations of false advertising by claiming that their denials of engaging in unfair labor practices and subjecting workers to unsafe working conditions were actually protected speech related to matters of public concern. Nike initially prevailed at trial and in the California Court of Appeals but lost on reversal in California Supreme Court – sending it to the High Court. While the U.S. Supreme Court accepted the case, they eventually sent it back down as “improvidently granted” – meaning they should not have accepted it in the first place – although Justice John Paul Stevens noted that the case presented “novel First Amendment questions because the speech at issue represents a blending of commercial speech and debate on issues of public importance.” Unfortunately, the case was settled before the issues at hand could be resolved with further clarification of just how free corporate speech can be on matters of public interest.

Despite some limited protection in narrow circumstances, there is strong judicial backing of the principle that companies cannot hide behind perceived First Amended rights to lie to or mislead investors. Some courts have found that outlining the factual basis for an opinion leads to First Amendment protection; however, Circuit Courts of Appeals have generally found that punishing securities fraud does not violate the First Amendment and laws punishing fraudulent speech survive constitutional scrutiny even when applied to pure, fully protected speech. In fact, in 2009, the Fourth Circuit explicitly found that “Punishing fraud, whether it be common law fraud or securities fraud, simply does not violate the First Amendment.” The Supreme Court has also stated, as cited by Suffolk Superior Court Justice Karen Green in Exxon: “the First Amendment does not shield fraud.”

It is well-settled law that the First Amendment does not protect fraud, and so courts are unlikely to prevent investors from enforcing their rights to be protected from false and misleading statements under the guise of free speech. Securities fraud defendants will certainly continue to use the tactic of improperly hiding behind the First Amendment to shield themselves from liability for false or misleading statements. However, they should be wary -- especially in the age when outspoken corporate officers can find themselves just one tweet away from destroying shareholder value with misguided, misleading, and potentially fraudulent comments.

The Government Should Tread Carefully in Its Short Seller Investigation

POMERANTZ MONITOR | MARCH APRIL 2022

By Veronica V. Montenegro

In February 2022, it was revealed that the Department of Justice (“DOJ”) and the U.S. Securities and Exchange Commission (“SEC”) commenced an investigation into dozens of investment firms and researchers engaged in short selling. It is not clear yet who on the list is considered a “target” of the probe and who might just have information relevant to the investigation, but the business of short selling in general has caught the attention of regulators.

Short sellers identify a stock that they believe will suffer a decline and borrow shares of that stock from a broker in order to sell them to buyers willing to pay the current market price. If the stock drops, the short sellers make a profit when they return the shares to the broker and buy them at a cheaper price. A short squeeze occurs if the price goes up, and the investors need to rush to buy the stock to cut their losses. Many of those under investigation have made a profession from exposing corporate fraud while betting that companies’ share prices will fall. For their part, some executives, accusing short sellers of targeting their companies for profit, have put pressure on the DOJ and other financial regulators to investigate short sellers for market manipulation. During the early 2021 meme-stock mania, short sellers were especially vilified by retail investors and the Reddit “Wall Street Bets” crowd who intentionally drove up the price of stocks of companies like GameStop and AMC Entertainment, which were heavily shorted at the time. The short squeeze on GameStop saw its share price jump from $17.25 to $325 over the course of just four weeks, posing the risk of catastrophic losses for short sellers as the share price skyrocketed.

It is not entirely clear what the DOJ’s and SEC’s specific allegations of wrongdoing might be, but The Wall Street Journal has reported that federal prosecutors are investigating whether short sellers conspired to drive down stock prices by engaging in illegal trading tactics such as “spoofing” and “scalping.” Spoofing involves flooding the market with a series of fake orders in order to manipulate the stock price without the intention of actually buying the stock. Illegal scalping (as opposed to “legal scalping”) is a short seller influencing investors or otherwise manipulating prices with the intent to sell the stock secretly and profit from the manipulation. U.S. prosecutors are reportedly exploring whether they can bring related charges under the Racketeer Influenced and Corrupt Organizations Act (“RICO”).

The short sellers’ practice of publicizing negative research and profiting when the stock falls has been criticized by those who argue that the allegations can be false and that the traders are artificially deflating share prices to the detriment of shareholders. However, short sellers may be an invaluable source for uncovering corporate wrongdoing and outright fraud. Such short seller reports uncovered fraud at Enron and other corporations and warned of the impending financial crisis in 2008. While companies targeted by short sellers rejoice at the government’s investigation, others believe that the inquiry is premised on the mistaken belief that abuse is widespread and distorting stock prices. Columbia Law Professor Joshua Mitts, one of the biggest critics of short selling, has proposed SEC rules which would require short sellers to hold their position for at least 10 days after releasing their negative research, or be accused of market manipulation for rapidly closing their positions. However, if such rules were to be implemented, they would deprive short sellers—who provide a vital service in policing the markets—of profiting from their research and short positions. In a 2018 research paper titled “Short and Distort,” Professor Mitts looked at 1,720 negative short seller reports and found that the stock prices of targeted companies began to recover just one day after the negative research was published and continued to recover for three days thereafter.

Critics have argued, however, that Professor Mitts did not examine a representative sample of activist short sellers and their reports. For example, Dealbook reported that an analysis shared by Carson Block, the activist short seller who founded Muddy Waters Capital, found that 75% of the negative reports analyzed in “Short and Distort” are not in a database of activist short seller campaigns compiled by Activist Insight, a leading provider.

Additionally, only 20% of the authors of those reports stated that they were shorting the stock of the companies on which they were reporting. Professors Frank Partnoy (Law School at the University of California, Berkley) and Peter Molk (University of Florida Levin College of Law) analyzed 825 negative research reports located in the Activist Insight database between 2009 and 2016 and found that, four years after the release of the reports, the average stock price decline of 573 targeted companies was more than 20%.

The SEC has not indicated whether it will adopt Professor Mitts’ proposed rules, but the government should move carefully when designing rules that can hamstring short selling as a viable profession. Many respected professionals in the securities field believe short selling plays an important role in public markets by improving price discovery and rational capital allocation, preventing financial bubbles, and finding fraud. In the securities class action space specifically, negative research reports authored by short sellers may play a vital role in alerting the market and investors that fraud has been committed by the company. These reports are often cited in class action lawsuits as revealing the truth of the fraud to the market, thereby serving as the “corrective disclosure”—a necessary component of a securities class action. Defendant companies frequently move to dismiss short seller claims, arguing that loss causation cannot be predicated on their reports as corrective disclosures because, among other reasons, the authors had a financial incentive to convince others to sell.

Unfortunately, various federal courts have sided with defendants on this point, with or without the existence of a financial incentive. Even though the information contained in such reports is revelatory of a previously undisclosed fraud, the reports should nevertheless qualify as corrective disclosures. If government action makes short selling a nonviable profession, class action investors would no longer be able to count on their reports to help make their case against fraudulent companies. Additionally, government action that further stigmatizes the role of short sellers could cause federal courts to take an even more skeptical view of short seller reports when analyzing the loss causation element of a securities class action lawsuit. To be clear, securities fraud, in whatever form it takes, should be prosecuted and punished—short selling firms should not be the exception. If the government investigation reveals that the targeted short selling firms have in fact engaged in illegal trading tactics, prosecution is warranted. However, it cannot be denied that short sellers and their reports have aided defrauded investors in prosecuting their cases.

The government should be diligent in ensuring that its investigation targets actual potential market manipulation and is not influenced by disgruntled corporate executives who are simply upset that their companies were subjects of hard-hitting research that revealed fraudulent activity.

Proposed Expanded Scope of Insider Trading Liability

POMERANTZ MONITOR | MARCH APRIL 2022

By Terrence W. Scudieri

On February 15, 2022, the U.S. Securities and Exchange Commission (the “SEC”) published a Proposed Rule in the Federal Register that, if adopted, will significantly expand the scope of liability for insider trading under Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), by limiting the scope of the current affirmative defense provided under SEC Rule 10b5-1 (the “Proposed Rule”). In general, to qualify for the Rule 10b5-1 affirmative defense, a corporate insider may avoid liability for trading on the basis of material, nonpublic information (“MNPI”) if its trade is pursuant to a contract, instruction, or plan that is adopted prior to the insider becoming aware of MNPI (a “Plan”), which either (1) specifies the amount, price, and date of securities to be traded; (2) provides written instructions or a formula that would trigger a trade of securities; or (3) does not allow the insider to influence whether, how, or when trades are made after the Plan is effective. The Proposed Rule signals a revival of the remedial intent of the securities laws: “to insure honest securities markets and thereby promote investor confidence” (United States v. O’Hagan). Indeed, “[a] significant purpose of the Exchange Act was to eliminate the idea that the use of inside information for personal advantage was a normal emolument of corporate office” (In re Cady, Roberts & Co.).

Background

Under Section 10(b), it is unlawful to use or employ, in connection with the purchase or sale of any security, “any manipulative or deceptive device or contrivance in contravention of [the SEC’s regulations].” For decades, courts have held that insider trading on the basis of MNPI is a “deceptive device” within the meaning of Section 10(b) and Rule 10b-5.

In 1997, the Supreme Court set forth two “theories” of MNPI insider trading liability under Section 10(b) and SEC Rule 10b-5. The first, known as the “traditional” or “classical theory,” is relevant here, while the second, known as the “misappropriation theory,” does not target unlawful trading by insiders, but instead “outlaws trading on the basis of nonpublic information by a corporate ‘outsider’ in breach of a duty owed not to a trading party, but to the source of the information.”

The classical theory posits that “Section 10(b) and Rule 10b-5 are violated when a corporate insider trades in the securities of his [or her] corporation on the basis of material, nonpublic information. Trading on such information qualifies as a ‘deceptive device’” within the meaning of Section 10(b) because “a relationship of trust and confidence exists between the shareholders of a corporation and those insiders who have obtained confidential information by reason of their position with that corporation,” such that an insider owes a fiduciary “duty to disclose or to abstain from trading” on the basis of MNPI. This theory of liability “applies not only to officers, directors, and other permanent insiders of a corporation, but also to attorneys, accountants, and others who temporarily become fiduciaries of a corporation.”

In August 2000, the SEC promulgated Rule 10b5-1, which clarifies whether an insider’s purchase or sale of an issuer’s securities was “on the basis of” MNPI and under what circumstances such a transaction was tantamount to a “manipulative and deceptive device,” thus giving rise to liability for securities fraud under Section 10(b). In doing so, the current Rule 10b5-1(c)(1) expressly excludes from its definition such insider trades as are made pursuant to a Rule 10b5-1 “plan;” that is, pursuant to a “binding contract to purchase or sell the security” or a “written plan for trading securities” that was ostensibly adopted before an insider became aware of MNPI. These “10b5-1 trading plans are designed to allow corporate insiders to ‘plan future transactions at a time when he or she is not aware of material nonpublic information without fear of incurring liability’” (Sec. & Exch. Comm’n v. Mozilo).

Problematically, current Rule 10b5-1 trading arrangements are often abused “to conduct share repurchases to boost the price of the issuer’s stock before sales by corporate insiders” (Proposed Rule, 87 Fed. Reg. at 8688). Accordingly, the SEC has published the Proposed Rule “to address apparent loopholes in the rule that allow corporate insiders to unfairly exploit information asymmetries.”

Three Key Proposed Changes

The Proposed Rule offers several amendments. This article addresses three of the most beneficial proposed changes for investors: the Proposed Rule would (1) add a 120 day mandatory “cooling off” period before any trading can commence under a Rule 10b5-1 trading arrangement after its adoption, cancellation, or modification; (2) require officers and directors to certify in their SEC filings that they are not aware of any MNPI before adopting a Rule 10b5-1 trading arrangement; and (3) require each issuer to disclose in their annual reports whether it has adopted insider trading policies and procedures, and to disclose such policies and procedures (or the lack of such policies and procedures and the reasons why).

First, at present, there is no mandatory waiting period between the time an issuer adopts a Rule10b5-1 plan and when an officer or director makes a trade pursuant to that plan. The Proposed Rule would prohibit officers and directors from making any trades pursuant to a Rule 10b5-1 plan within 120 days of adopting, cancelling, or modifying such a plan (Proposed Rule, 87 Fed. Reg. at 8689 90). This change is critical, as it should work to solve the current problem of insiders adopting a Rule10b5-1 plan and making trades pursuant to that plan on the same day.

Second, at present, there is no current requirement that officers or directors certify their ignorance of any MNPI before invoking a Rule10b5-1(c) affirmative defense. The Proposed Rule would require officers and directors to certify, at the time of the adoption of the trading arrangement,” that “they are not aware of [MNPI] about the issuer or its securities” and that “they are adopting the [Rule 10b5-1 plan] in good faith and not as part of a plant or scheme to evade [Section 10(b) or Rule 10b-5]” (Proposed Rule, 87 Fed. Reg. at 8691). If adopted, this change may provide an additional basis for Section 10(b) liability.

Third, at present, there is no requirement that issuers disclose in their SEC filings whether they have enacted policies and procedures to protect MNPI from misuse by insiders. The Proposed Rule would require all issuers to disclose (1) their insider trading policies and procedures in their annual SEC reports and (2) whether an issuer, officer, or director used a Rule 10b5-1 trading plan during a reportable quarter in their quarterly SEC reports (Proposed Rule, 87 Fed. Reg. at 8693 94). If adopted, this change may provide an additional basis for Section 10(b) liability.

Conclusion

The Proposed Rule would make many positive changes, and investors are encouraged to review it in full. The SEC is accepting public comments until April 1, 2022, after which it is expected to adopt a Final Rule.

Q&A - Gustavo Bruckner

POMERANTZ MONITOR | MARCH APRIL 2022

By The Editors

Gustavo F. Bruckner leads Pomerantz’s Corporate Governance practice group, enforcing shareholder rights and litigating against corporate actions that harm shareholders.

Monitor: What is a shareholder derivative case?

Gustavo Bruckner: Whether an investor owns one share or one million shares, they are an owner of that company. The company itself is just a legal creation, an inanimate object that cannot respond when it is harmed or wronged. But a shareholder, as an owner, can take action on behalf of the company to remedy that harm. And that’s what a shareholder derivative action is. It’s usually directed against the officers and directors who sit at the top of the company and wouldn’t otherwise take action against themselves.

M: One share versus one million shares… Is weight given to that in court in corporate governance cases?

GB: The other side often tries to make it an issue. There was a recent hearing where a shareholder owned a fractional share of Tesla in one account and many more in another. Tesla argued that the shareholder didn’t own enough to review its books and records. The Vice Chancellor of Delaware’s Chancery Court shut down that argument very quickly. There are jurisdictions where you need to own a certain minimum threshold of the shares to pursue derivative litigation – 5% in Nevada, for example – but not in Delaware, which is the most common forum for these kinds of actions. The law does not specify a minimum; the only thing the law specifies is the ownership stake at the time the litigation is brought. For the most part, one share or a million shares is the same under the law.

M: #MeToo issues like sexual harassment are sensitive matters to the victims involved. How do you maintain discretion and confidentiality?

GB: Our goal is not to promote ourselves. Our goal is to forcefully and effectively represent our institutional and individual clients. If the best way to address the misconduct, remedy the harm, and bring about change is to do it privately, then we will do so. And we’ve had many, many such resolutions. No one will ever know except the parties involved that Pomerantz, on behalf of its clients, caused those changes. It won’t appear in any court docket or in the news. But we cause real substantive, meaningful change through our prosecutions and through the cudgel of litigation.

M: This misconduct is often hidden from public view. How can shareholders gain insight into concealed wrongdoing?

GB: It sometimes comes to our attention through aggrieved parties or whistleblowers. Stockholders may reach out to us based on their feeling that something just doesn’t pass the smell test. And I’ve even had more than one experience where a competitor has said that a situation is worthy of investigation. When you’ve been doing this long enough, you know what doesn’t seem right.

M: What do you foresee being the most important governance matter facing corporations over the next decade?

GB: There are several things at play. We mentioned fractional investing earlier. Robinhood and other similar services have democratized investing even further so shareholder ownership will continue to evolve and look very different from the past. This is already leading to very strong pushes for activism in areas such as climate change, diversity, executive compensation and social action. Companies will have to figure out how to balance the need to maximize stockholder profit while also achieving the social goals of its ownership. Often, maximizing profit for shareholders is at direct odds with achieving ESG goals. And then there are the rules governing corporate behavior. We are already seeing a couple of instances where corporations are trying to avoid or preempt state oversight by adopting bylaws that limit the kinds of actions that can be brought. That may be something that will come to a head in the next few years.

M: On the topic of executive compensation, can you speak to the importance of clawbacks?

GB: The clawback is a tool that every corporation should avail itself of when there is harm caused by executive misconduct but, for a multitude of reasons, companies refuse to both adopt and implement clawback and fallback policies. They claim that if they adopt policies that are too strong, they won’t be able to attract the best and brightest executives. That seems ridiculous to me. Are you recruiting from the white-collar section of the prison to hire your executives? We’re intentionally pretty forceful in looking at clawback policies whenever we investigate a company for misconduct. Many clawback policies only kick in if there’s a financial statement. The largest securities action of the last five or so years was Petrobras. There was no financial restatement in that, so that situation would not have allowed shareholders to go after company executives even after decidedly corrupt and illegal behavior.

M: Over the course of your career, what is the most important corporate governance reform that you have achieved?

GB: It’s actually confidential, but what I can say is that Pomerantz sent a litigation demand to a major entertainment company after reports of sexual harassment. As a result, we were able to negotiate reforms that included formation of a special committee of the company’s board and creation of a Fair Employment Practices Group, along with complete retraining of all of their U.S. employees. The company also agreed to institute increased opportunities for reporting of harassment via the web and phone and we required that reports of harassment reached the highest levels at the company. I am quite proud of this one, feeling it has made a difference for the people there.

Pomerantz Corporate Governance Roundtable

With Special Guest Speaker President Bill Clinton

Pomerantz, in association with The Corporate Governance Institute, Inc., is pleased to announce the agenda for the upcoming Corporate Governance Roundtable Event on June 14, 2022, that it will host at the Waldorf Astoria Hotel in Beverly Hills, California. We are honored that President Bill Clinton will be the special guest speaker.

President Clinton served as the 42nd President of the United States and is the founder of the Clinton Foundation. During his time in office, President Clinton led the U.S. to the longest economic expansion in American history, including the creation of more than 22 million jobs. He was also the first Democratic president in six decades to be elected twice. Roundtable attendees can look forward to hearing President Clinton, widely renowned as a gifted speaker, share his perspectives and experiences.

The Roundtable will gather institutional investors from around the globe to discuss their evolving role in managing the risk of governance and ESG challenges under the theme: The Collective Power to Make Change. This one-day event will combine the knowledge and experience of fiduciaries, legal counsel and governance professionals with the opportunity to discuss important matters that affect the value of the funds they represent. This year’s panels and presentations include the following topics:

Covid-19 and the Litigation Pandemic: The COVID-19 pandemic has produced a tidal wave of new litigation. This session will provide insight into this evolving legal landscape.

Corporate Governance Developments: A discussion of current global trends in corporate governance and a look forward at emerging issues that governance professionals may face in the coming year.

Forced Arbitration and the Repercussions for Institutional Investors: Over the last several years, there have been indications that the SEC is considering allowing corporations to use forced arbitration clauses to curtail investors’ rights to bring securities class actions. This panel will discuss Colorado PERA’s and the CII’s decision to intervene in an action in which a shareholder, represented by an anti-class action activist, seeks to have Johnson & Johnson shareholders vote on a contentious proxy proposal. The proposal concerns a corporate bylaw that would require all securities fraud claims against Johnson & Johnson to be pursued through mandatory arbitration, thus waiving shareholders’ rights to bring securities class actions.

Fiduciary Duty & ESG Priorities in 2022: This session will explore how institutional investors can balance their interest in promoting adherence to good ESG principles at the companies in which they invest with their fiduciary duties to protect investments and maximize fund performance.

Securities Litigation Update: Engagement & Litigation: General Counsel from some of the most influential global institutional investors will discuss their attitudes toward securities litigation and what other tools they employ to hold corporations accountable.

Inside the Boardroom: This panel will discuss how directors address board diversity within their own organizations and how their internal approach impacts their interactions with the boards of companies with which they entrust their investments.

Jennifer Pafiti, Partner and Head of Client Services at Pomerantz, has been involved in organizing the Firm’s Roundtable Events since 2015: “These events bring peers together to discuss current issues that directly affect the asset value of the funds they represent. More importantly, though, this setting allows experts within their field to share ideas, opinions and best practices, which adds real value to fiduciaries’ day-to-day roles.”

To express your interest in attending this special event, please email PomerantzRoundtable2022@pomlaw.com